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Abstract (English) 
 
In this doctoral thesis, the mechanism of the Lewis base-mediated aza-Baylis-Hillman 
reaction was examined. Intermediates of the reaction were intercepted and structurally 
characterized, an extensive kinetic study was performed and the effects of Brønsted acidic co-
catalysts on the reaction mechanism were examined. In addition, other mechanistic aspects 
like reversibility, stability of the stereocenter and chirality transfer from the catalytic system 
to the reaction product were studied. 
 This mechanistic study provided useful information for the rational design of an 
appropriate chiral catalytic system. Several potential catalytic systems were synthesized and 
tested. The most successful system involved a reaction medium, an ionic liquid, as the source 
of chirality. With this system, enantioselectivities up to 84% ee were obtained in the 
triphenylphosphine-catalyzed aza-Baylis-Hillman reaction of aromatic tosylaldimines and 
methylvinyl ketone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IV
 
Abstract (German) 
 
Im Rahmen dieser Doktorarbeit wurde der Mechanismus der Lewis-Basen-katalysierten aza-
Baylis-Hillman-Reaktion untersucht. Reaktionsintermediate wurden abgefangen und 
strukturell charakterisiert, die Kinetik der Reaktion wurde eingehend untersucht und die 
Auswirkungen von Brønsted-sauren Cokatalysatoren wurden studiert. Zusätzlich wurden 
weitere mechanistische Aspekte der Reaktion wie Reversibilität, Stabilität des Stereozentrums 
und Chiralitätstransfer vom katalytischen System auf das Reaktionsprodukt behandelt.  
 Diese mechanistische Studie lieferte wertvolle Informationen für den rationellen 
Entwurf eines geeigneten chiralen Katalysatorsystems. Das erfolgreichste System umfasste 
als Chiralitätsquelle ein Reaktionsmedium, eine ionische Flüssigkeit. Mit diesem System 
konnten in der triphenylphosphin-katalysierten aza-Baylis-Hillman-Reaktion von 
aromatischen Tosylaldiminen mit Methylvinylketon Enantioselektivitäten von bis zu 84% ee 
erreicht werden. 
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1. Objective  
 
The objective of this Ph.D. thesis was to develop novel chiral catalytic systems for the 
organo-mediated asymmetric aza-Baylis-Hillman reaction, an atom efficient C-C bond 
forming reaction leading to highly functionalized chiral allylic amines.[1] The system should 
be based on nitrogen- or phosphorus-containing nucleophilic Lewis base organocatalysts. 
 
In principle two general strategies were viable to achieve this goal: 
 
(1) A combinatorial approach involving a screening of a broad variety of potential catalyst 
structures for the aza-Baylis-Hillman reaction. These compounds should either be 
commercially available or attainable via a short and straightforward synthetic route. 
(2) The rational design of suitable chiral catalytic systems based on insights into the 
mechanism of the aza-Baylis-Hillman reaction and, more specifically, into the 
mechanism of chirality transfer. 
 
Since the first strategy had turned out to be widely unsuccessful in the search for 
appropriate chiral catalysts for related organocatalytic C-C couplings like the Baylis-Hillman 
reaction, the second strategy was elected.[2] There was no information available on the 
mechanism of the aza-Baylis-Hillman reaction at the beginning of this Ph.D. study 
(November 2003), so extensive mechanistic research in the initial stage of the project was 
necessary. This involved the interception and characterization of reaction intermediates as 
well as a full kinetic analysis of the reaction catalyzed by nucleophilic Lewis bases with and 
without potential co-catalysts. Furthermore, aspects like chirality transfer, reversibility and 
product stability were of high interest. 
 The implications of these mechanistic findings should provide information for the 
rational design of novel chiral catalytic systems. In addition to the conventional approach of 
applying chiral organocatalysts in the aza-Baylis-Hillman reaction, the use of well designed 
chiral solvents as carriers of chiral information in a catalytic system should be explored in this 
present work. 
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2. Introduction 
 
2.1. Asymmetric Organocatalysis 
 
2.1.1. General Aspects 
 
The term ORGANOCATALYSIS was introduced by MacMillan in 2000 and is used to describe a 
research area involving reactions which are mediated by metal-free, small organic 
compounds.[3],[4]  Scheme 1 shows a selection of typical chiral organocatalysts. 
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Scheme 1. A selection of chiral organocatalysts. 
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Organocatalysis complements the classical domains of metal- and enzyme catalysis and 
provides useful new strategies for organic synthesis. Organocatalysts have several advantages 
over transition-metal catalysts and enzymes: they are usually robust, inexpensive and readily 
available. Because of their robustness they often do not require demanding reaction conditions 
like inert gas atmosphere and absolute solvents.  
Whereas synthetic organic chemists have started to explore organocatalysis 
systematically in the past decade, it is suggested that this field of catalysis has a long history: 
Pizarrello and Weber reported evidence for a key role of organocatalytic processes in the 
formation of important chiral prebiotic building blocks like sugars.[5] It was proposed that 
aminoacids from carbonaceous meteorites, which carried the same sign L as terrestrial amino 
acids, were delivered to the Earth in its early history via showering of the planet with 
cometary and asteroidal material. As chiral organocatalysts they could be responsible for the 
enantioselective synthesis of sugars. Furthermore, the authors reported that it is likely that 
similar organocatalytic processes are responsible for the propagation of chirality in living 
organisms.  
The first examples of asymmetric organocatalytic processes, in which synthetically 
useful enantioselectivities were obtained, date from the early sixties of the past century. 
Pracejus reported the use of optically active amines like acetylquinine (12) as catalysts for the 
reaction of phenylmethyl ketene (10) with alcohols[6] or amines (Scheme 2).[7]  
 
O
CH3OH+
12
O
O
toluene, −111°C
10                                  11                                                      13
OAc
N
N
O
93%
74% ee  
 
Scheme 2. Addition of methanol (11) to phenyl methyl ketene (10) as reported by Pracejus. 
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In the early seventies, both the group of Hajos and Parrish[8] at Hoffmann-La Roche 
and the group of Eder, Sauer and Wiechert[9] at Schering reported the L-proline-catalyzed 
intramolecular aldol reaction, which nowadays carries their names (Scheme 3).   
 
O
O
1 (3 - 47 mol-%)
CH3CN, r.t. - 80°C
O
O
83% - quant.
71 - 93% ee
14 15O
 
 
Scheme 3. The Hajos-Parrish-Eder-Sauer-Wiechert reaction. 
 
Despite these early successes it took a long time for synthetic organic chemists to 
recognize and appreciate the broad scope of asymmetric organocatalysis. Only in the past 
decade enantioselective organocatalysis became a main focus of research. In 2000, List and 
Barbas reported pioneering studies on organocatalytic intermolecular aldol reactions[10] 
parallelled by a report of the group of MacMillan on enantioselective organocatalytic Diels-
Alder reactions[3] in the same year (Scheme 4 and 5, respectively). These studies elucidated 
the promising potential of organocatalytic transformations and resulted in a large scientific 
interest in this area of research.[11]  
 
O
O
1 (30 mol-%)
DMSO, r.t.
+
O OH
16 17 18
97%
96% ee  
 
Scheme 4. L-Proline-catalyzed intermolecular aldol reaction reported by Barbas and List.  
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O
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2 (5 mol-%)
23°C
82%
94% ee (endo/exo 14:1) 
 
Scheme 5. First enantioselective organocatalytic Diels-Alder reaction reported by the group 
of MacMillan. 
 
Several criteria can be applied to categorize the large amount of organocatalytic 
reactions reported in literature in the past few years, such as the type of catalyst employed or 
the type of reaction that is catalyzed.[11] The mechanistic classification by List involves a 
division of the organocatalytic processes into four categories, according to their 
mechanisms:[4],[12] 
 
(1) Lewis Base Catalysis 
(2) Lewis Acid Catalysis 
(3) Brønsted Base Catalysis 
(4) Brønsted Acid Catalysis 
 
Despite the sometimes limited information on mechanisms of organocatalytic reactions and 
the fact that not all organocatalytic processes can be described with these general reaction 
mechanisms, this division will be adopted in this manuscript to give a brief survey of the large 
diversity of asymmetric organocatalytic reactions reported in literature. 
 
2.1.2. Lewis Base Catalysis 
 
The general catalytic cycle for reactions catalyzed by Lewis bases (B:) is shown in Scheme 6. 
This type of process starts with a nucleophilic addition of the Lewis base B: to the substrate S, 
which leads to the adduct B+-S−. This adduct undergoes a reaction to the intermediate species 
B+-P−, from which the product (P) is released. The catalyst is set free and re-enters the 
catalytic cycle. 
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Scheme 6. General mechanism for Lewis base-catalyzed reactions. 
 
Prototypical examples of reactions catalyzed by Lewis bases are the reactions shown in 
Scheme 4 and 5. The intermolecular aldol reaction, shown in Scheme 4, proceeds through the 
enamine intermediate 24 which is formed by deprotonation of the primarily formed iminium 
ion 23 (Scheme 7).[10a],[13]  
 
O
HN
COOH
+ N
COOHOH
- H2O
N
CO2
N
COOH
+ RCHO
16 1 22
2324
25
aldol
product
 
 
Scheme 7. The formation of the enamine intermediate 24 (R = alkyl, aryl). 
 
Enamine 24 undergoes an electrophilic attack from aldehyde 25 which leads to the aldol 
product after subsequent hydrolysis. Further examples of so-called ENAMINE CATALYSIS are 
the Hajos-Parrish-Eder-Sauer-Wiechert reaction (Scheme 3),[8],[9] Mannich reaction,[14] 
Michael addition[15] and α-functionalization of ketones and aldehydes (α-amination,[16] α-
hydroxylation,[17] α-alkylation,[18] α-halogenation).[19] 
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 The Diels-Alder reaction in Scheme 5 proceeds through the iminium intermediate 26 
(IMINIUM CATALYSIS,[13] Scheme 8).[3] 
 
O + N
- H2O
20 2 26
N
H
N
Bn
O
N
Bn O
 
 
Scheme 8. The formation of the iminium intermediate 26. 
 
In case of the Diels-Alder reaction, shown in Scheme 5, the α,β-unsaturated aldehyde 20 
forms an iminium coumpound with the chiral imidazolidinone catalyst 2. In comparison to the 
unsaturated aldehyde 20, the LUMO energy of the iminium ion 26 as dienophile is lowered.[3]  
In general, an iminium ion is more reactive than its corresponding carbonyl compound 
and consequently facilitates reactions such as [3+2]-cycloadditions,[20] Friedel-Crafts 
alkylation with pyrroles, indoles and benzenes,[21] and Mukayiama-Michael reactions.[22]  
 Other N-Lewis base-catalyzed processes mainly proceed through acyl-ammonium[23] 
and ammonium-enolate intermediates[24] (e.g. Baylis-Hillman reaction, see chapter 2.2.2). 
Although the majority of chiral Lewis bases for organocatalysis are N-based compounds, C- 
(nucleophilic carbenes, generated from precursors like 7),[25], P-[26] and S-Lewis bases[27]  are 
also applied as chiral organocatalysts.  
 
2.1.3. Lewis Acid Catalysis 
 
Lewis acid catalysts (A) activate nucleophilic substrates (S:) which leads to the formation of 
the adduct A−-S+.  This adduct is converted into the adduct A−-P+, followed by elimination of 
the product (P). This enables the catalyst (A) to re-enter the catalytic cycle (Scheme 9). 
A large class of organocatalysts which can be referred to as Lewis acids are phase 
transfer catalysts such as 5.[28] This catalyst was successfully applied to enantioselective α-
alkylations as well as aldol- and Michael reactions.[29] A further example of Lewis acid 
catalysis is the asymmetric oxidation method reported by Shi.[30] 
 
  11
 
 
Scheme 9. General mechanism for Lewis acid-catalyzed reactions. 
 
2.1.4. Brønsted Base Catalysis 
 
Organocatalytic processes, initiated by Brønsted bases (B:), start with a (partial) 
deprotonation of the substrate S-H.  The cycle proceeds through the intermediates B+H S− and 
B+H P−. Elimination of the product (P-H) enables the catalyst (B) to re-enter the catalytic 
cycle (Scheme 10). 
 
 
 
Scheme 10. General mechanism for Brønsted base-catalyzed reactions. 
 
Prototypical examples of reactions catalyzed by Brønsted bases are hydrocyanations such as 
Strecker reactions (S = CN).[31] The dipeptide species 3 was reported as a successful catalyst 
for this type of reactions.[32] It is postulated that in this reaction hydrogen cyanide interacts 
with the nitrogen base to form a cyanide ion, which subsequently adds to the carbonyl or 
imine compound coordinated to the chiral peptide via hydrogen bonding.  
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2.1.5. Brønsted Acid Catalysis 
 
 
Brønsted acid-catalyzed reactions start with a (partial) protonation of the substrate (S:). The 
resulting adduct A− S+H is converted into the adduct A− P+H, which undergoes an elimination 
reaction to liberate the product (P) and the catalyst (A-H) (Scheme 11).[33] 
 
 
 
Scheme 11. General mechanism for Brønsted acid-catalyzed reactions. 
 
Jacobsen and co-workers used urea- and thiourea compounds as chiral Brønsted acids to 
activate carbonyl- and imine groups in a broad variety of reactions: Strecker-,[34] Mannich-,[35] 
Henry-,[36] hydrophosphonylation-,[37] and aza-Baylis-Hillman reactions.[38] These catalysts 
activate carbonyl- or imine substrates by hydrogen bonding of the (thio)urea catalyst to the 
carbonyl oxygen or imine nitrogen, respectively.  
Rawal reported the use of TADDOL derivatives (28) as chiral catalysts for the hetero-
Diels-Alder reaction (Scheme 12).[39]  
  
TBSO
N
O
R
+
OH
OH
O
O
Ar Ar
Ar Ar
(20 mol-%)
toluene, −40°C - −78°C
27 25
28
O
RTBSO
N
+ CH3COCl
29
30
O
RO
31
52 - 97%
86 - 98% ee 
 
Scheme 12. Hetero-Diels-Alder reaction catalyzed by TADDOL derivatives (R = aryl, alkyl). 
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Protecting one or both hydroxy-groups leads to a decrease in activity and selectivity, 
indicating the involvement of both OH groups in the activation of the carbonyl compound. 
McDougal and Schaus reported an enantioselective variant of the Baylis-Hillman 
reaction, catalyzed by BINOL derivatives.[40] This will be discussed in more detail in chapter 
2.2.3. 
 
2.1.6. Bifunctional Acid-Base Catalysis 
 
In the past few years, several groups showed that the incorporation of a basic and an acidic 
moiety in one chiral molecule can facilitate a synergistic interaction between the functional 
groups and thereby lead to an efficient bifunctional chiral organocatalyst. 
One of the first examples of a bifunctional chiral organocatalyst was reported by the 
group of Takemoto in 2003.[41] They used catalyst 34 which contains an amine moiety and a 
thiourea group (Scheme 13).   
 
NO2
CO2Et
CO2Et
+
H
N
S
H
NF3C
CF3
N
(10 mol-%)
toluene, r.t.
NO2
CO2EtEtO2C
86%
93% ee
32 33
34
35
 
 
Scheme 13. Michael addition of diethyl malonate (33) to trans-β-nitrostyrene (32). 
 
In this system, the amino group serves as a Brønsted base and activates the nucleophile via 
(partial) deprotonation. The thiourea group − a Brønsted acidic catalyst − coordinates to the 
nitro function of the α,β-unsaturated olefin. The results obtained with catalyst 34 in the 
Michael addition of malonates to a range of different nitroolefins are good to excellent (up to 
93% ee). 
 Since then, bifunctional organocatalysts were successfully applied to a wide range of 
reactions. Catalysts containing both a Brønsted basic- and a Brønsted acidic group were 
applied to Michael additions,[42] Henry reactions,[43] aza-Henry reactions,[44] Strecker 
reactions[45] and kinetic resolution of azlactones.[46] The combination of a Lewis basic 
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(nucleophilic) and a Brønsted acidic group works well for Baylis-Hillman (see chapter 
2.2.3.)[47] and aza-Baylis-Hillman reactions (see chapter 2.3.3.).[48]  
 
2.2. Baylis-Hillman Reaction 
 
2.2.1. General Aspects 
 
The Baylis-Hillman (BH) reaction was first described by Morita et al.[49] and later, in a 
German patent, by Baylis and Hillman.[50] It involves the atom-efficient coupling of an 
activated alkene in its α-position with a carbonyl compound and is mediated by a nucleophilic 
Lewis base. As prototypical example of the BH reaction, the coupling of benzaldehyde (36) 
with methylvinyl ketone (MVK, 37) catalyzed by 1,4-diazabicyclo[2.2.2]octane (DABCO, 
38) is shown in Scheme 14. 
 
OO
+
N
N
OH O
36 37 39
38
 
 
 
Scheme 14. BH reaction of benzaldehyde (36) with MVK (37) catalyzed by DABCO (38). 
 
The reaction shows an enormous diversity in substrates.[2] As activated alkenes alkyl vinyl 
ketones, alkyl (aryl) acrylates, acrylonitrile, vinyl sulfones, acryl amides, allenic esters, vinyl 
sulphonates, vinyl phosphonates, acrolein, crotonitrile, crotonic acid esters and phenyl vinyl 
sulfoxide can be used.[2] They couple with aliphatic, aromatic and heteroaromatic aldehydes, 
α-keto esters, non-enolizable 1,2-diketones and fluoroketones.[2] Simple ketones require high 
pressure to react as electrophiles in the BH reaction.[51] The BH coupling of activated alkenes 
with imines – the aza-BH reaction – is discussed in chapter 2.3. A further variant of the BH 
reaction involves the coupling of activated alkenes with sp3 hybridized electrophiles (alkyl 
halogenides) – the so-called BH alkylation.[52] 
 The products of the BH reaction are highly functionalized chiral allylic alcohols of 
type 39. They are useful intermediates for the synthesis of more complex organic structures 
like anti-tumor agents,[53] anti-biotics[54] and natural products.[55] The potential of the reaction 
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is further illustrated by its application in industrial processes. tert-Butyl-2-
(hydroxymethyl)propenoate, a key intermediate in Pfizer’s synthetic route to the Zn-
metallaprotease inhibitor Sampatrilat, is prepared via BH coupling on a 40 kg scale.[56] 
 In principle, the reaction can be mediated by various types of catalysts. In all cases, a 
nucleophilic Lewis base, which can be an amine,[57] phosphine,[58] sulphide[59] or selenide,[59] 
is part of the catalytic system. Lewis-[60] and Brønsted acids[40] can be added as co-catalysts. 
With sulfides and selenides, it is necessary to use a Lewis acidic co-catalyst (e.g. TiCl4) to 
obtain a useful catalytic activity.[59] The research described in this thesis focuses solely on 
phosphine- and amine catalysts and Brønsted acids as potential co-catalysts. 
 
2.2.2. Mechanism 
 
Several studies contribute to the understanding of the mechanism of the BH reaction. The 
generally accepted reaction intermediates have been intercepted and structurally characterized 
by using electrospray ionization with mass and tandem mass spectroscopy.[61] Further 
experimental evidence is delivered by the group of Drewes through isolation of the second 
zwitterionic intermediate (type-41, see Scheme 15) as coumarine salt.[62] The catalytic cycle 
of the BH reaction based on the intermediates, which are intercepted and characterized in 
these studies, is shown for the prototypical reaction of benzaldehyde (36) with MVK (37) 
(Scheme 15). 
The reaction starts with a 1,4-addition of the nucleophilic catalyst 38 to the activated 
olefin 37, which leads to the formation of the zwitterionic 3-ammonium enolate 40. Enolate 
40 is then converted to the second zwitterionic intermediate 41 by aldol-type coupling with 
36. The last step involves a proton migration from the α-carbon to the alcoholate oxygen and 
release of the catalyst (38) which provides the BH product 39. There is some discussion in 
literature regarding the configuration of 40 and 41. Some groups report evidence for an open 
isomer as the reactive species, [52b],[63] other groups postulate a (Z)-isomer with a Nu+-O− 
stabilization.[64] In Scheme 15, the enolate geometry is therefore left undefined which is 
indicated by a wavy bond. 
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Scheme 15. Catalytic cycle for the BH reaction of 36 with 37 based on the intercepted and 
characterized intermediates. 
 
 All steps of the catalytic cycle are potentially reversible.[65] The reaction has a high 
negative activation volume which explains the increase of the reaction rate of the typically 
slow BH reaction under high-pressure conditions (about 5-15 kbar) reported by several 
groups.[66] In some cases, even stereo- and enantioselectivity are affected by a change in 
pressure.[67],[51b]  
Three mechanistic models are postulated to explain the results obtained in different 
kinetic studies. The first model – the so-called CLASSICAL MODEL – was developed by Kaye 
and co-workers to interpret the kinetic data obtained for the BH reaction of acrylate esters 
with pyridine carboxaldehydes in CDCl3.[68] They monitored the reaction via NMR 
spectroscopy and observed a first-order dependence in catalyst, aldehyde, and acrylate and 
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postulated a mechanism which contained the intermediates shown in Scheme 15 with the 
aldol-coupling as the rate determining step (RDS).  
The second model – the so-called HEMI-ACETAL MODEL – was developed by the group 
of McQuade to explain their kinetic results.[69] They investigated the reaction of various 
aromatic aldehydes with methyl acrylate (42) both in non-protic polar solvents like DMSO 
and THF and under protic conditions. With rate- and isotope data, they showed that the 
reaction is second order in aldehyde and that the α-C-H bond breaks in the RDS. To include 
the second equivalent of aldehyde, they altered the cycle shown in Scheme 15 and proposed 
the formation of an additional hemi-acetal type intermediate – intermediate 43 – which 
preceded the proton migration (Scheme 16). This model was further supported by the 
observation of dioxanones as typical by-products of the BH reaction when the acrylate ester 
was a reasonable leaving group and the aldehyde concentration was high.[70] Furthermore, 
they reported a first order dependence on solvent and a solvent-induced acceleration which 
roughly followed the dielectric constant of the solvent or solvent mixture. They explained 
these results as a medium effect in which the ionic transition states of the BH reaction were 
stabilized in the presence of polar solvents. 
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Scheme 16. Hemi-acetal intermediate 43 as postulated by McQuade. 
 
The third proposed mechanism is the so-called AUTOCATALYSIS MODEL.[71]  Aggarwal 
and Lloyd-Jones investigated the reaction between benzaldehyde (36) and ethyl acrylate (44) 
catalyzed by quinuclidine (45) without the use of a solvent. In a competition experiment with 
α-deuterated ([D]44) and non-deuterated ethyl acrylate (44), they observed a substantial 
increase of the mole fraction of [D]44 in the early stages of the reaction (< 20% conversion). 
As the reaction proceeded, the ratio 44/[D]44 reached a constant level. This was explained 
with a scenario where in the early stage of the reaction, the proton migration was rate limiting 
but became increasingly efficient during the course of the reaction which ultimately resulted 
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in a shift of the RDS from the proton migration to the aldol-type coupling. They rationalized 
these findings by a model in which the product serves as a co-catalyst through facilitation of 
the proton migration from the α-keto methine to the alkoxide making the reaction 
autocatalytic. They postulated a proton transfer via transition state 46 (Scheme 17). 
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Scheme 17. Transition state for product-assisted proton migration according to Aggarwal and 
Lloyd-Jones (product = ROH).[71] 
 
The AUTOCATALYSIS MODEL, including the TS depicted in Scheme 17, also explained the 
large rate enhancements in the BH reaction caused by water and other protic solvents or 
additives.[72] At the end of their report, the authors postulated a model for enantioselective BH 
reactions with bifunctional chiral catalysts containing a Lewis basic and a Brønsted acidic 
moiety and discussed the implications of their mechanistic findings for asymmetric catalysis 
(Scheme 18).  
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Scheme 18.  Model for enantioselective BH reactions by Aggarwal and Lloyd-Jones (Nu∩OH 
= chiral bifunctional catalyst). 
 
Since the second intermediate of the BH reaction (type 41) contained two centers of chirality, 
four diastereoisomers could be formed with an enantiopure catalyst. The authors suggested 
that all four diastereoisomers (D1-4) of the “type-41 intermediate” should be formed during 
the reaction, but only one had the hydrogen-bond donor suitably positioned to allow an 
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effective proton transfer. The other diastereoisomers would revert back to the starting 
materials and eventually the reaction would “filter” through the pathway that leads to fast 
elimination. This implied that the proton migration step determined the enantioselectivity of 
the reaction and that the reaction itself could be regarded as a dynamic kinetic resolution of 
the intermediate of type 41 which is shown in Scheme 18. Other models explaining the 
enantioselectivity in catalytic asymmetric BH reactions for specific catalyst systems are 
discussed in the next chapter.  
 
2.2.3. Catalysts 
 
As already mentioned, the BH reaction can be mediated by nucleophilic Lewis bases or by 
combined Lewis base/Lewis acid or Lewis base/Brønsted acid systems. Only the systems 
based on N- and P-Lewis bases (in combination with Brønsted acids) will be discussed here in 
more detail.  
 Suitable N-Lewis base catalysts for the BH reaction are compounds like DABCO 
(38),[73] quinuclidine (45),[74] 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 47),[75] imidazole 
(48)[76] and 4-dimethylaminopyridine (DMAP, 49) (Scheme 19).[77]  
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Scheme 19. Typical N-Lewis base catalysts for the BH reaction. 
 
These Lewis bases can be divided into two categories. The first group contains highly 
nucleophilic and unhindered Lewis bases like DABCO (38) and quinuclidine (45). Because of 
their high nucleophilicity they enable the efficient formation of the 3-ammonium enolate 
(type-40) which leads to a high overall reaction rate. The second group consists of catalysts 
which can stabilize this 3-ammonium enolate by delocalization of the positive charge on 
nitrogen (e.g. 47-49) (Scheme 20). 
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Scheme 20.  Stabilization of the DBU-containing 3-ammonium enolate (50) of methyl 
acrylate (42). 
 
 Typical P-containing Lewis bases for the BH reaction are trialkylphosphines like P(n-
Bu)3 (51),[78] PEt3 (52) and the air-stable trialkylphosphine 1,3,5-triaza-7-phosphaadamantane 
(PTA, 54) (Scheme 21).[79] Due to their reduced nucleophilicity, triarylphosphines like PPh3 
(53) can only initiate the reaction in the presence of a suitable co-catalyst like phenol.[80] 
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Scheme 21. Typical P-Lewis base catalysts for the BH reaction. 
 
 As already mentioned before, Brønsted acids are efficient co-catalysts for the BH 
reaction and lead to significant rate enhancements. Typical protic additives which are used to 
increase the efficiency of BH reactions are for example methanol,[81] water,[82] (thio)ureas,[83] 
and phenols.[40] Both catalytic moieties can also be incorporated in one catalyst. A simple 
example is 3-quinuclidinol (55), which in general shows a much higher catalytic activity than 
quinuclidine (45) itself due to the formation of hydrogen bonds in the corresponding 
intermediates.[84] This concept of applying a bifunctional catalyst in BH reactions has proven 
to be successful in asymmetric catalytic variants. 
 The first successful chiral catalyst that resulted in synthetically useful 
enantioselectivities in the BH reaction has been developed only recently.  1999, Hatakeyama 
and co-workers applied the cinchona alkaloid derivative 56 as catalyst for the BH reaction of 
various aldehydes with 1,1,1,3,3,3-hexafluoroisopropyl acrylate (57) (Scheme 22).[47b] 
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At −55°C in DMF they obtained the corresponding products (58) in enantioselectivities up to 
99% ee. 
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Scheme 22. Reaction of various aldehydes with 57 under the catalytic influence of 56 (R = 
C6H5, p-NO2C6H4, CH3CH2, C6H11 etc).  
 
The explanation for the high enantioselectivity as given by the authors was based on three 
features of catalyst 56: 
 
(1) its increased nucleophilicity in comparison to related compounds like quinidine 
(2) the presence of the free phenolic-OH group at the quinoline ring 
(3) the anti-open conformation of catalyst 56 
 
The authors postulated that the anti-open conformation allowed an optimal stabilization of 
zwitterion 60 through intramolecular hydrogen bonding (Scheme 23). 
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Scheme 23. Postulated stabilization of intermediate 60 with Hatakeyama’s catalyst 56.  
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Since the chirality of the catalyst is fixed and intermediate 60 contains two chiral centers, A 
and B, four diastereoisomers can be formed in this stage of the reaction. The authors 
postulated that diastereoisomer 60, depicted in Scheme 23, is the most stable and has a nearly 
ideal conformation for the subsequent elimination reaction. Elimination from the catalyst in 
intermediate 60 leads to the BH product with the stereoconfiguration of 58. A major 
disadvantage of Hatakeyama’s catalytic system is the formation of relatively large amounts of 
the dioxanone by-product 59 which suppresses the yield of the BH product 58. These 
dioxanone by-products are formed in opposite stereoconfigurations and worse 
enantioselectivities as compared to 58. This dioxanone formation, however, contributed to the 
mechanistic understanding of the BH reaction (cf. HEMI-ACETAL MODEL). Catalyst 56 was 
subject of further studies to expand the scope of substrates[85] and has also been applied in the 
synthesis of natural products.[86] Other bifunctional chiral catalysts for the BH reaction which 
contain both catalytic moieties in one chiral molecule, are the cinchona-alkaloid derivative 61 
(pseudo-enantiomer to 56),[87] N-methylprolinol (62)[88] and the amine-thiourea catalyst 63 
(Scheme 24).[89] 
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Scheme 24. Recent examples for bifunctional chiral catalysts for the BH reaction. 
 
Examples of efficient systems with chiral Brønsted acidic co-catalysts in combination 
with simple achiral nucleophiles like DABCO (38) and PEt3 (52) are based on L-proline 
(1),[90] BINOL derivatives (64),[40] the bis-thiourea compound 65[91] and pipecolinic acid (66) 
(Scheme 25).[92] 
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Scheme 25. Chiral co-catalysts for the BH reaction (X = H, Br, Ph etc). 
 
 There are only few non-bifunctional chiral catalyst systems for the BH reaction 
reported in literature. Hayashi and co-workers reported a chiral diamine catalyst with 
enantioselectivities up to 75% ee.[93] As a chiral biphosphine catalyst, BINAP resulted in 
enantioselectivities up to 44% ee.[94] 
 
2.3. Aza-Baylis-Hillman Reaction 
 
2.3.1. General Aspects 
 
The aza-Baylis-Hillman (aza-BH) reaction – the coupling of activated alkenes with imines – 
was first reported by Perlmutter and Teo in 1984 (Scheme 26).[1] This atom-efficient C-C 
bond forming reaction is, in analogy to the BH reaction, usually catalyzed by nucleophilic 
Lewis bases like DABCO (38) and leads to highly functionalized chiral allylic amines (68).  
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Scheme 26. Aza-BH reaction of N-benzylidene-4-methylbenzenesulfonamide (67) with ethyl 
acrylate (44), catalyzed by DABCO (38).  
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The reaction is flexible towards the choice of starting materials. As electrophiles, 
various activated aromatic aldimines like tosyl-,[48b],[93] nosyl-[38] and phosphinoylimines[95] 
can be used. The reaction can also be performed as a three component reaction in which 
aldehyde, activated alkene and tosylamide[96] or diphenylphosphinamide[97] are coupled in one 
pot. Furthermore, sulfinimines[98] and azadicarboxylates[99] can be applied in the aza-BH 
reaction. 
 The spectrum of Michael acceptors, which can be used for this reaction, is even 
broader.[100] MVK, acrolein, phenyl acrylate, α-naphthyl acrylate, methyl acrylate, 2-
cyclopentenone and 2-cyclohexenone as well as other β-substituted activated alkenes were 
reported as suitable Michael acceptors.[101] Also, activated allenes and alkynes are appropriate 
substrates.[102] 
In the presence of P(n-Bu)3 (51) as Lewis base the aza-BH reaction of aldimines like 
67 with cyclic α,β-unsaturated ketones like 2-cyclohexenone (69) can result in the formation 
of the expected aza-BH product 70 along with the bicyclic by-product 71 (Scheme 27).[103]  
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Scheme 27. Formation of the bicyclic compound 71 under aza-BH reaction conditions. 
 
The mechanism postulated for the formation of 71 starts with a Mannich-type coupling of 72 
and 67 which results in the formation of 73. In the next step, intermediate 73 undergoes 
intramolecular Michael addition and subsequent protonation to form 71.  
Another substrate combination which can lead to unexpected (by-)products under aza-
BH reaction conditions is 67/MVK (37) (Scheme 28).[104] In the case of PPh3 (53) as catalyst, 
the expected aza-BH product 77 was the only observed reaction product. With P(n-Bu)3 (51) 
  25
as catalyst under otherwise identical reaction conditions, the only observed products were 74 
and 75. The proposed mechanism that explains the formation of these products involves the 
hemi-aminal intermediate 78. In case of the BH reaction, a similar intermediate (hemi-acetal) 
is postulated to explain the formation of dioxanones as by-products as well as specific kinetic 
results (see chapter 2.2.2. and 2.2.3.).  
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Scheme 28. Unexpected products for the reaction of 67 with 37. 
 
The synthetic potential of the aza-BH reaction is illustrated by its integration into 
synthetic routes. It is, for example, used for the synthesis of PEG-supported α-methylene-β-
aminoesters,[105] substituted pyrroles[106] and 2,5-dihydropyrroles.[107]  
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2.3.2. Mechanism 
 
At the beginning of this Ph.D. study (November 2003) no information was available on the 
mechanism of the aza-BH reaction. It was assumed that the catalytic cycle of the reaction 
contained intermediates similar to those commonly accepted for the BH reaction (Scheme 29).  
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Scheme 29. Assumed catalytic cycle for the aza-BH reaction. 
 
In parallel to the work described in this thesis, Jacobsen and co-workers investigated the 
reaction between the aromatic nosyl-aldimine 83 and methyl acrylate (42) (Scheme 30).[38] 
They published their results almost simultaneously with our first communication on the 
reaction mechanism. 
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Scheme 30. Reaction of the nosyl imine 83 with methyl acrylate (42), catalyzed by DABCO 
(38) and thiourea 84. 
 
As catalyst they used a combined system of the Lewis basic nucleophile DABCO (38) and the 
Brønsted-acidic chiral thiourea 84 in xylene. They observed a yellow precipitate during the 
course of the reaction and spectroscopically identified it as the second intermediate of the 
catalytic cycle 86 (Scheme 31). Upon treatment with an excess of hydrochloric acid, they 
could isolate and characterize the dihydrochloride salt 87 as a glassy solid. 
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Scheme 31. Isolation and characterization of the dihydrochloride salt 87 of intermediate 86 by 
the group of Jacobsen. 
 
Intermediate 86 (and its corresponding dihydrochloride salt 87), which resulted from a 
Mannich-type coupling of the corresponding zwitterionic 3-ammonium enolate with imine 83 
was obtained in high diastereomeric purity (d.r. > 10/1) with a relative stereochemistry of the 
major isomer assigned as anti. Furthermore, they disclosed that 86 could racemize under turn-
over conditions. This stereochemical lability was explained by the reversibility of the 
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Mannich-type coupling step which would create a racemization pathway for 86 in which the 
Brønsted acidic co-catalyst did not play a role (Scheme 32). 
 
CO2MePh
NH
Nos
N
N
H
2  Cl-
87
DBU (47)
rac-85 + 83 42+
trace amount
 
 
Scheme 32. Racemization under turn-over conditions. 
 
Because the reaction mixture for the reaction disclosed in Scheme 30 was not 
homogeneous, kinetic experiments could not be performed for that exact system. Therefore 
the group of Jacobsen studied the reaction of imine 83 with methyl acrylate (42) without co-
catalyst in CHCl3 which provided a homogeneous mixture during the complete course of the 
reaction. They monitored the conversion by GC analysis and analyzed their data with the 
method of initial reaction rates.[108] The reaction showed a first order kinetic dependence on 
both DABCO (38) and methyl acrylate (42). In contrast to the BH reaction, they observed rate 
saturation for the imine 83 as electrophile.  
In kinetic isotope effect studies using α-deuterated methyl acrylate ([D]42) they 
disclosed a prominent primary kinetic isotope effect (kH/kD = 3.81), which strongly suggested 
that a cleavage of the α-CH(D) bond was involved in the RDS (RDS = proton 
migration/elimination).  
To determine the influence of the electrophile on the elimination reaction, they 
investigated the DBU (47)-mediated elimination of 87 in methanol via IR spectroscopy.  They 
found a first-order reaction rate profile for more than 4 half-lives, which was consistent with a 
rapid and irreversible deprotonation of 87 to 86, followed by intramolecular proton transfer. 
Since added imine had no effect on the rate of elimination, they concluded that the 
electrophile did not play a role in mediating the elimination step thereby excluding a pathway 
similar to the HEMI-ACETAL MECHANISM postulated by McQuade for the BH reaction.[69] 
Further mechanistic investigations were carried out by the groups of Sasai and Shi 
focussing on the origin of enantioselectivity in their specific systems. The results of these 
studies will be discussed in the next chapter. 
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2.3.3. Catalysts 
 
In accordance with the BH reaction, the aza-BH reaction can be mediated by nucleophilic 
Lewis bases, by Lewis bases in combination with Lewis acids[109] and by combined Lewis 
base/Brønsted acid systems. Only the systems based on N- and P-Lewis bases (with Brønsted 
acid) will be discussed here in more detail. 
 In general, the achiral nucleophilic N- and P-containing Lewis bases, which were 
discussed as catalysts for the BH reaction, can also be applied to mediate the aza-BH reaction. 
For the asymmetric aza-BH reaction, however, different catalytic systems are applied.  
 One of the most successful chiral catalytic systems for the aza-BH reaction was 
developed by Shi and co-workers in 2003.[110] They developed the P-based catalyst 88 which 
carried a Brønsted acidic phenol moiety and tested it initially for the coupling of aromatic 
tosylaldimines like 67 with simple Michael acceptors like MVK (37) and phenyl acrylate 
(Scheme 33). Depending on the substitution pattern of the aromatic tosylaldimine, 
enantioselectivities up to 97% ee were obtained.  
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Scheme 33. Reaction of the aromatic tosylaldimine 67 with MVK (37), catalyzed by 88. 
 
 In further studies, the substrate scope of this catalytic system was investigated.[48b],[111] 
Besides aromatic tosylaldimines like 67, aromatic mesyl-, p-chlorobenzenesulfonyl- and β-
trimethylethanesulfonyl (SES) aldimines could be used. The catalyst was inactive in reactions 
with aliphatic aldimines.  
 As Michael acceptor, MVK, ethyl vinyl ketone (EVK), phenyl acrylate, α-naphthyl 
acrylate, β-naphthyl acrylate and acrolein could be used. Reactions with methyl acrylate 
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proceeded in a very sluggish way with low enantioselectivities (typically about 20% ee). β-
Substituted Michael acceptors proved inactive with 88. Replacement of the PPh2 group with a 
more nucleophilic PMe2 group, however, resulted in a suitable chiral catalyst system for 
reactions with this type of Michael acceptors.  
 In addition, the authors carried out some mechanistic investigations on their system. 
The phenolic OH group turned out to be crucial for the success of the catalyst.[112] The 
introduction of substituents in 3, 6 or 6’ position of 88 did not result in significant changes in 
activity and selectivity. Replacement of the PPh2 group with a P(o-tolyl)2 group, however, 
yielded an inactive system, which indicated that the steric bulk around the P-atom played a 
key role in initiating the aza-BH reaction. Furthermore, the authors characterized the “type-81 
intermediate” of 88 with 37 via NMR spectroscopy. They suggested a stabilization of this 
intermediate by hydrogen bond interaction of the phenolic OH group with the enolate oxygen. 
They explained the success of their chirality transfer with a model similar to that postulated 
by Hatakeyama and co-workers for catalyst 56 (page 21). 
 A second system based on a phosphorus-containing Lewis base was developed by 
Sasai and co-workers in 2006.[113] They attached a phosphine unit through an aromatic ring to 
the 3-position of (S)-BINOL as a chiral Brønsted acid and tested the system for the reaction of 
imine 67 with MVK (37) (Scheme 34).  
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Scheme 34. Reaction of imine 67 with MVK (37) catalyzed by 90. 
 
They obtained enantioselectivities up to 95% ee, albeit with a very slow reaction rate. When 
both catalytic moieties of this bifunctional catalyst were positioned in a way that no 
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synergistic interaction between the Lewis base and the Brønsted acid could occur in an 
intramolecular fashion, the selectivity decreased dramatically.  
 Similar results were reported by the same group for a nitrogen containing bifunctional 
system which was introduced in 2005.[114] They investigated the reaction of aromatic 
tosylaldimines like 67 with MVK (37) catalyzed by the bifunctional catalyst 91 (Scheme 35). 
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Scheme 35. Reaction of 67 with 37 catalyzed by the bifunctional catalyst 91. 
 
In a mixture of toluene and cyclopentyl methyl ether (CPME) at −15°C, enantioselectivities 
up to 96% ee could be obtained for aza-BH reactions between aromatic tosylaldimines and 
simple Michael acceptors like MVK, EVK and acrolein. The authors showed that activity and 
enantioselectivity of the catalytic system were severely dependent on the exact position of the 
active units within the catalyst.[48a] Many similar catalysts which contained different spacers 
between the catalytic moieties and/or different positions of the pyridine nitrogen relative to 
the Brønsted acidic group were often inactive and non-selective. Only when both catalytic 
functions were correctly positioned within the organocatalyst, a synergistic interaction was 
possible which resulted in an efficient bifunctional chiral catalyst. In a more extensive 
mechanistic study, they disclosed that the catalytically active groups of catalyst 91 are the 
pyridine-N atom and the phenolic OH group in 2’-position.[48a] 
 A fourth bifunctional system which proved effective in mediating the aza-BH reaction 
of aromatic tosylaldimines involves the BH catalyst 56. Both the group of Shi[115] and the 
group of Adolfsson[116] showed that catalyst 56 did not only efficiently catalyze the BH but 
also the aza-BH reaction. The substrate scope of this catalytic system was fairly broad: MVK, 
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EVK, acrolein, methyl acrylate, phenyl acrylate and naphthyl acrylates could be used as 
Michael acceptors. Furthermore, the reaction could be performed enantioselectively as a three 
component coupling of aldehyde, tosylamide and activated alkene. With catalyst 56, 
enantioselectivities up to 99% ee were obtained. This successful transfer of chirality was 
explained by a mechanistic model similar to that for the BH reaction with 56 as catalyst. 
 In principle, it is also possible to decouple both catalytic moieties. As already partially 
described in 2.3.2., Jacobsen and co-workers used chiral thiourea derivatives like 84 in 
combination with simple achiral nucleophiles like DABCO (38).[38] They investigated the 
coupling of aromatic nosylaldimines like 83 with methyl acrylate (42) and obtained the 
corresponding reaction products in enantioselectivities up to 99% ee. The activity of this 
catalytic system, however, was low to moderate. Furthermore, the observed inverse 
relationship between chemical- and optical yield for this system leaves no room for 
improvement. In addition, the substrate scope is, to date, very limited. 
 
2.4. Chiral Solvents for Asymmetric Synthesis 
 
A chemical reaction that leads to enantiomerically enriched products can in principle be 
carried out with a source of chirality in any of the involved components – starting 
materials,[117] catalysts,[118] or solvents.[119] The strategy of applying chiral solvents in 
asymmetric synthesis was pioneered by Seebach and Oei.[120] They used a chiral aminoether 
as the solvent in the electrochemical reduction of ketones but observed only low 
enantioselectivities (up to 23.5% ee). Since then, all attempts to apply chiral solvents in 
asymmetric synthesis have resulted in similar or lower enantioselectivities, which led to the 
generally accepted conclusion that “asymmetric induction caused by chiral solvents is usually 
rather small”.[119]  
As ionic liquids (ILs), however, recently attracted a lot of attention as a new class of 
solvents,[121] the incorporation of chiral information in these media has caught the interest of 
several groups.[122] A selection of chiral ions, used for the synthesis of chiral ILs, is shown in 
Scheme 36.  
The first contribution to this area of research was made by the group of Seddon and 
co-workers in 1999.[123] They introduced [bmim] lactate (92) as anion-chiral IL, which was 
prepared by ion metathesis of sodium lactate with [bmim] chloride. Application of this IL as a 
solvent for the Diels-Alder reaction of ethyl acrylate with cyclopentadiene, however, did not 
result in a transfer of chirality from the reaction medium to the corresponding reaction 
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product. Although this first application of a chiral IL as reaction medium was rather 
unsuccessful, Seddon’s study initiated the synthesis of a broad spectrum of chiral ILs, as 
shown in Scheme 36. 
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Scheme 36. A selection of chiral ions which are used for the synthesis of chiral ILs. 
 
In 2001 Wasserscheid and co-workers developed a first set of ILs containing chiral 
cations including ephedrinium based ILs (96).[124] Very recently, Vo-Thanh and co-workers 
used these ILs as solvent for the DABCO-catalyzed BH reaction of benzaldehyde and methyl 
acrylate.[125] With this IL, they obtained the first significant asymmetric induction caused by a 
chiral IL as the only source of chirality in an asymmetric reaction. The corresponding BH 
product 101 was obtained in an enantiomeric excess of up to 44% (Scheme 37).   
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Scheme 37. BH reaction in the ephedrinium IL 100. 
 
Further examples of asymmetric induction caused by cation-chiral ILs as solvents were 
reported by Armstrong and co-workers (photoisomerization of 
dibenzobicyclo[2.2.2]octatriene diacid, ee up to 11%)[126] and by the group of Bao (Michael 
additions of malonates to enones, ee up to 25%).[127] No significant asymmetric induction has 
been reported so far for anion-chiral ILs. 
 The comparatively high enantioselectivities obtained in the BH reaction of 
benzaldehyde and methyl acrylate indicate that the application of chiral ILs as the source of 
chirality in organocatalytic processes can be a promising strategy to obtain the corresponding 
products in valuable enantioselectivities. A potential reason for the comparatively high 
enantioselectivity in this reaction may be a strong interaction of the zwitterionic reaction 
intermediates (transition states) with the chiral ions of the solvent. Possible modes of 
interaction with ILs are electrostatic attraction and, in case of IL 100, hydrogen bonding. 
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3. Results and Discussion 
 
3.1. Mechanistic Investigation of the Aza-Baylis-Hillman Reaction 
 
3.1.1. Kinetic Study 
 
3.1.1.1. Lewis Base Catalysts 
 
In initial experiments, kinetic measurements were performed on the catalytic system which 
contained only a Lewis base catalyst. As a model reaction, the aza-BH coupling of N-(3-
fluorobenzylidene)-4-methylbenzenesulfonamide (102) with MVK (37) in the presence of 
triphenylphosphine (53) as catalyst was examined (Scheme 38). The reaction was carried out 
in THF at room temperature.  
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Scheme 38. Model reaction for kinetic study of the Lewis base-catalyzed aza-BH reaction. 
 
The first method considered for this study was on-line IR spectroscopy. In cooperation 
with Patrick Bäuerlein from the group of Dr. Lasse Greiner, the reaction could be monitored 
via IR spectroscopy in an Argon-glovebox. For this purpose, an ATR-IR sensor from the 
company INFRARED FIBER SENSORS was used, which measures the wave-length dependent 
attenuation of the intensity of the IR signal for the total reflection at a diamond crystal.[128] 
The laser beam was injected and released through a fiber optical cord. The probe and the 
setup in the glovebox are depicted in Figure 1.  
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Figure 1. ATR-IR probe from INFRARED FIBER SENSORS, mounted for reaction monitoring in 
a glovebox.  
 
The main advantage as compared to other potential analysis techniques (e.g. NMR 
spectroscopy, vide infra) was the velocity of the measurement and the high flexibility of the 
probe as a result of the attached fiber optics. A major disadvantage, however, was the 
complexity of the handling and analysis of the obtained data involving operations like base 
line corrections and curve fitting. Furthermore, an external reference was necessary for an 
appropriate quantification. Although the data that were obtained with this technique were in 
accordance with data obtained from 1H NMR spectroscopic studies, the disadvantages of this 
method outweighed its advantages for the aza-BH reaction.[129] 
As a second method NMR spectroscopy was considered. A general advantage of 
NMR- over IR-spectroscopy was the easy data handling. An important drawback of this 
technique, however, was the inability to obtain data during the first minutes of a reaction due 
to experimental factors (lock/shim). Since the aza-BH reaction was a relatively slow process, 
this disadvantage played only a minor role in this kinetic study. Consequently, NMR 
spectroscopy was elected as the method of choice for these investigations. Furthermore, the 
use of the fluorinated electrophilic coupling partner 102 allowed reaction monitoring via 19F 
NMR spectroscopy. In consequence, the use of large amounts of expensive deuterated 
solvents like [D8]THF which would be necessary for 1H NMR spectroscopic measurements, 
could be avoided. Hexafluorobenzene (104) was applied as internal standard.  
  
Typical concentration-time profiles that were obtained with 19F NMR spectroscopy, 
are shown in Figure 2.  
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Figure 2. Typical concentration-time profiles. Starting concentrations: c (102) = 0.1514 
mol⋅l−1, c (37) = 0.1531 mol⋅l−1, c (104) = 0.0285 mol⋅l−1, c (53) = 0.0724 - 0.1595 mol⋅l−1.  
 
The concentration-time profiles were fitted with a polynomial of fourth order 
(Equation 1). The initial reaction rate was determined through differentiation (Equation 2).  
 
pdtctbtattc ++++= 234)(                                        ℜ∈pdcba ,,,,     Equation 1 
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The initial reaction rate was analyzed as a function of the starting concentration of the 
individual components.  The corresponding plots are shown in Figure 3a-d. 
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Figure 3a. Partial order in imine 102. Starting concentrations: c(53) = 0.0501 mol⋅l−1, c(37) = 
0.1438 mol⋅l−1, c(104) = 0.0243 mol⋅l−1, c(102) = 0.0998-0.2530 mol⋅l−1. 
 
log r(0) = 0,4685log c(imine) + 3,0243
R2 = 0,9908
3,00
3,10
3,20
3,30
3,40
3,50
3,60
0,50 0,60 0,70 0,80 0,90 1,00 1,10
log c(imine) 
lo
g 
r(
0)
 
 
Figure 3b. Partial order in imine (double-logarithmic). 
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Figure 3c. Partial order in MVK (37). Starting concentrations: c(53) = 0.0500 mol⋅l−1, c(102) 
= 0.1506 mol⋅l−1, c(104) = 0.0214 mol⋅l−1, c(37) = 0.1712 – 0.3163 mol⋅l−1. 
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Figure 3d. Partial order in PPh3 (53). Starting concentrations: c(37) = 0.1531 mol⋅l−1, c(102) 
= 0.1514 mol⋅l−1, c(104) = 0.0285 mol⋅l−1, c(53) = 0.0724 – 0.1595 mol⋅l−1. 
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These results demonstrated that the reaction showed a first order dependence in Michael 
acceptor (37) and catalyst (53). To determine the non-integer order in imine (102), the data 
were analyzed by using a double-logarithmic plot (Figure 3b).[130] The gradient of this plot 
corresponded to a partial reaction order of approximately 0.5 (Equation 3). 
 
)()()(5.0 hosphinepcacceptorMichaelcimineckr obs ⋅−⋅⋅=       Equation 3 
  
A comparison of these data to the kinetic results obtained by Aggarwal and Lloyd-Jones for 
the autocatalytic BH reaction revealed that the aza-BH coupling was no autocatalytic process 
under the conditions applied in this kinetic study.[71] A HEMI-ACETAL MECHANISM, as 
proposed by McQuade for the BH reaction in aprotic solvents, could also be ruled out.[69] 
Based on the rate law in Equation 3, however, no autonomous mechanism for the Lewis base-
catalyzed aza-BH reaction could be postulated. A mechanistic interpretation of these data will 
be provided in the next chapter by comparison to the kinetic data of the aza-BH reaction 
mediated by a bifunctional Lewis Base-Brønsted acid catalyst system. Similar kinetic results 
for the aza-BH reaction catalyzed by nucleophilic Lewis bases were independently reported 
by the group of Jacobsen.[38]  
3.1.1.2. Lewis Base-Brønsted Acid Catalysts 
 
In a second set of experiments, the influence of Brønsted acidic additives (co-catalysts) on the 
reaction of N-(4-bromobenzylidene)-4-methylbenzenesulfonamide (105) with MVK (37) in 
[D8]THF was examined (Scheme 39).  
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Scheme 39. Reaction of imine 105 with MVK (37), catalyzed by the system PPh3 
(53)/Brønsted acid. 
 
A set of Brønsted acids with pKA values in the range of 4 to 16 was screened as potential 
additives for this model reaction.[131] Approximately one equivalent of Brønsted acid per 
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imine was used. A strong influence of strength of the Brønsted acid on the rate of the reaction 
was observed (Table 1, Figure 4). 
 
Table 1. Influence of Brønsted acidic additives on the reaction rate. 
 
entry additive pKA relative initial rate 
1 malic acid 3.6 0.1 
2 - - 1.0 
3 aza-BH product (106) n.a. 1.2 
4 water 15.4 2.4 
5 methanol 15.5 3.7 
6 N-methyl-tosylamide 11.7 4.8 
7 benzoic acid 4.2 6.5 
8 phenol 9.9 7.3 
9 3,5-bis(CF3)phenol 8.0 13.9 
 
Starting concentrations: c(37) = 0.150 mol⋅l−1, c(105) = 0.125 mol⋅l−1, c(53) = 0.0125 mol⋅l−1 
and 0.172 mol⋅l−1 Brønsted acid in [D8]THF.  
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Figure 4. Influence of Brønsted acidic additives on the reaction rate.  
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A comparison of the relative initial rate of the reaction with the aza-BH product 106 as 
additive (entry 3) to the relative initial rate of the reaction without co-catalyst (entry 2) 
confirmed that the reaction was not autocatalytic under the applied conditions. A maximum in 
reaction rate was observed with 3,5-bis(CF3)phenol (107) (pKA ≈ 8, entry 9) as additive, 
corresponding to a 14-fold rate enhancement as compared to the reaction without additive 
(entry 2). Less acidic compounds showed a smaller effect (entry 4-6, 8). Additives, which 
were more acidic than 3,5-bis(CF3)phenol (107), ultimately even inhibited the reaction (entry 
1).  
NMR studies showed that this was mainly due to a protonation of the first zwitterionic 
reaction intermediate and to a minor extent to protonation of the nucleophilic catalyst itself 
(Scheme 40). 
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Scheme 40. Protonation of the nucleophilic catalyst and the first zwitterionic reaction 
intermediate. 
 
Treatment of a 1:1-mixture of PPh3 (53) with MVK (37) in [D8]THF at r.t. with one 
equivalent of malic acid resulted in a mixture of the corresponding 3-phosphonium enolate in 
its protonated form (109) and the triphenylphosphonium salt 110.  After 5 min all PPh3 was 
converted. A comparison of the signal intensities in the 31P NMR spectrum showed that the 
ratio 109/100 corresponded to a value of 95/5. These results are i.a. supported by a report 
from Wasserscheid and co-workers. They described a similar reaction as side reaction during 
the preformation of their metal-phosphine catalytic system for acrylate dimerisation.[132]  
Additionally, the rate law of the reaction was determined in the presence of phenol 
(111) as prototypical additive. The reaction was monitored by 19F NMR spectroscopy. The 
dependence of the initial rate on the starting concentration of imine is depicted in Figure 5. 
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Figure 5. Initial rate as function of starting concentration of the imine 102 in the presence of 
phenol as Brønsted acidic co-catalyst. Starting concentrations: c(53) = 0.0294 mol⋅l−1, c(37) = 
0.1502 mol⋅l−1, c(111) = 0.1584 mol⋅l−1, c(104) = 0.0341 mol⋅l−1, c(102) = 0.0962 – 0.1479 
mol⋅l−1. 
 
For the other curves r(0) = f(c(x)) {x = MVK (37) and phenol (111)}, see Appendix 3. 
A first order dependence in all components was observed, including the imine and Brønsted 
acid (Equation 4). 
 
)()()()('' acidcphosphinecacceptorMichaelcimineckr obs ⋅⋅−⋅⋅=           Equation 4 
 
These results are in line with the results obtained by Kaye in the so-called CLASSICAL MODEL 
for the amine-catalyzed BH reaction of pyridinecarboxaldehydes with acrylate esters.[68] This 
indicates, that the RDS of the aza-BH reaction catalyzed by the combined system Lewis Base-
Brønsted acid is the C-C coupling step, the Mannich reaction. 
A comparison of these results to the results obtained with a Lewis base catalyst alone 
(Equation 3), clearly indicates that the mechanism undergoes a change upon addition of the 
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Brønsted acidic co-catalyst.  A potential mechanistic interpretation of the change in the rate 
law – the partial order in imine changed from 0.5 to 1 – involves a shift of the RDS from the 
proton migration to the Mannich-type coupling reaction. Addition of a Brønsted acid 
facilitates the proton transfer which ultimately becomes so fast that it is not rate limiting 
anymore. This hypothesis is supported by the data, provided by Aggarwal and Lloyd-Jones in 
their mechanistic study on the BH coupling.[71] A plausible transition state, which explains the 
facilitation of the proton transfer, is shown in Scheme 41. Without Brønsted acid, the proton 
migration step most likely proceeds either through a 4-membered cyclic TS or in an 
intermolecular fashion. Addition of a suitable Brønsted acid (ROH) enables a facilitation of 
the migration step via 6-membered cyclic TS. 
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Scheme 41. Postulated transition state for the Brønsted acid-mediated proton transfer. 
  
Furthermore, the partial order of 1 in Brønsted acid indicates that the Brønsted acid also plays 
a role in the Mannich type reaction, probably through activation of the imine. At 
approximately one equivalent of Brønsted acid per imine, a start of saturation was observed 
(see Appendix 3). 
 
3.1.2. Reversibility of the Aza-Baylis-Hillman Reaction 
 
To assess the reversibility of the aza-BH reaction, both cross-Mannich (Scheme 42) and 
racemization experiments (Scheme 43) with the catalytic system PPh3 (53)/phenol (111) were 
performed.  
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Scheme 42. Cross-Mannich experiments with the catalytic system PPh3 (53)/phenol (111).  
Reaction conditions: 30.0 mg (0.0735 mmol, 1.00 eq) 106, 203.7 mg (0.735 mmol, 10.0 eq) 
102, 19.3 mg (0.0735 mmol, 1.00 eq) 53, 34.6 mg (0.367 mmol, 5.00 eq) 111, 2 ml (2.7 
ml⋅mmol−1) THF, r.t., n h. 
 
Figure 6 shows a direct comparison of kinetic results that were obtained with imine 102 and 
105, respectively, in the reaction with MVK (37). As catalytic system, the combined system 
PPh3 (53)/phenol (111) was applied.  
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Figure 6. Kinetic results obtained with imine 103 and 106, respectively. Starting 
concentrations: c(37) = 0.15 mol⋅l−1, c(103/106) = 0.13 mol⋅l−1, c(53) = 0.014 mol⋅l−1,  
c(111) = 0.15 mol⋅l−1in THF.  
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These results showed that the reactivity of imine 102 was higher than the reactivity of 105. 
Under turn-over conditions, however, the product of cross-Mannich reaction (103) was not 
observed even after prolonged reaction times (t = 72 h). 
A further probe for the reversibility of the reaction was the stability of the stereocenter 
of the aza-BH product 106 under turn-over conditions (Scheme 43). With the catalytic system 
PPh3 (53)/phenol (111), racemization of enantiomerically enriched 106 (ee = 88% (S)) was 
observed under turn-over conditions (Figure 7). The absence of cross-Mannich products under 
these conditions indicated that the racemization of the aza-BH product 106 was independent 
from the catalytic cycle. Further experiments to elucidate the mechanism of racemization are 
described below. 
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Scheme 43. Racemization experiments with the catalytic system PPh3 (53)/phenol (111). 
Reaction conditions: 38.1 mg (0.0933 mmol, 1.00 eq) 106, 24.5 mg (0.0933 mmol, 1.00 eq) 
53, 26.3 mg (0.280 mmol, 3.00 eq) 111, 0.75 ml (8.0 ml⋅mmol−1) THF, r.t., n h. 
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Figure 7. Racemization under turn-over conditions. Starting concentrations: c(106) = 0.125 
mol⋅l−1, c(53) = 0.125 mol⋅l−1, c(111) = 0.373 mol⋅l−1 in THF. 
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3.1.3. Racemization of the Aza-Baylis-Hillman Product 
 
Firstly it was investigated whether the C-C, C-H or C-N bond at the stereogenic center was 
broken during the racemization process. To obtain this information, the aza-BH product rac-
106 was treated with PPh3 (53) in [D4]methanol. The result of this experiment is shown in 
Scheme 44. 
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Scheme 44. Deuteration of rac-106 with [D4]methanol. Reaction conditions: 20.4 mg (0.050 
mmol, 1.00 eq) 106, 13.1 mg (0.l050 mmol, 1.00 eq) 53, 1.0 ml (20 ml⋅mmol−1) 
[D4]methanol, r.t., 5 h. 
 
As shown in Scheme 44, a proton-deuterium exchange was observed in several positions of 
106, also at the stereogenic center. This indicated that the C-H bond at the stereogenic center 
broke during the racemization process and thereby confirmed that racemization of the aza-BH 
product was not caused by retro-Mannich reaction.   
 In a further set of experiments, the role of all components in the racemization was 
investigated. The results are shown in Table 2. These experiments showed that racemization 
was not caused by simple deprotonation at the stereogenic center (entry 6). Also the presence 
of triphenylphosphine alone did not lead to product racemization (entry 1). Besides a 
nucleophilic catalyst a Brønsted acidic additive (entry 3) and/or imine (entry 4, 5) was 
necessary for racemization. With Shi’s phosphinyl-BINOL catalyst 88, however, no 
racemization was observed under the same conditions, even though the catalytic system 
contained all components identified in the model reaction.  This indicated that the spatial 
arrangement of a bifunctional catalytic system is of major importance for the prevention of 
racemization. This provides important information for the efficient design of successful chiral 
catalyst systems 
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Table 2. Role of all reaction components in the racemization process. 
 
entry system yes no 
1 PPh3   x 
2 phenol   x 
3 PPh3  +  phenol  x  
4 PPh3 + imine  x  
5 PPh3 +  phenol +  imine x  
6 KOH  x 
 
Reaction conditions: 40.0 mg (0.107 mmol, 1.00 eq) (S)-4-methyl-N-[2-methylene-1-(4-
nitrophenyl)-3-oxobutyl]-benzenesulfonamide (114), 28.0 mg (0.107 mmol, 1.00 eq) PPh3 
(53), 30.2 mg (0.321 mmol, 3.00 eq) phenol (111), 16.3 mg (0.053 mmol, 0.50 eq) N-(4-nitro-
benzylidene)-4-methylbenzenesulfonamide (113), 0.85 ml THF, r.t., 24 h. The experiment 
with KOH was performed in a biphasic system water/diethylether.  
 
To assess the influence of the Brønsted acidic additive on the rate of racemization, a 
screening of additives with pKA values of 4-16 was performed.[131] The influence of the 
Brønsted acidic additive on the racemization rate was determined by single point 
measurements of the enantiomeric ratio. The results are shown in Figure 8. 
The results depicted in Figure 8 show a clear dependency of the rate of racemization 
on the pKA value of the additive. Rapid and nearly complete racemization was observed with 
phenol (pKA = 9.90) as additive. Weak Brønsted acids like water and methanol caused no 
significant racemization on a relevant time scale. Stronger acidic additives resulted in a 
slower rate of racemization ultimately leading to a non-significant racemization.  
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Figure 8. Single point measurements for comparison of the influence of different Brønsted 
acidic additives on the rate of racemization. Reaction conditions: 38.1 mg (0.0933 mmol, 1.00 
eq) 106 (e.r. = 11.4 (S)), 211.1 mg (0.0933 mmol, 1.00 eq) PPh3 (53), 0.2799 mmol (3.00 eq) 
Brønsted acid, 0.75 ml THF, r.t., t = 24 h. 
 
A plausible model which explains these findings involves a racemization pathway in 
which both the nucleophilic catalyst and the conjugated base of the Brønsted acid play a 
crucial role (Scheme 45). All steps in this model are equilibrium reactions. When the 
Brønsted acid is strong (e.g. malic acid, pKA = 3.6), the conjugated base is relatively weak. It 
is easily formed but not able to deprotonate the stereogenic center. In case of very weak 
Brønsted acids (e.g. methanol, water, pKA ≈ 15.5), a protonation of enolate 115/116 does not 
take place and consequently the conjugated base, which is necessary for deprotonation at the 
stereogenic center, is not formed. Only for a small spectrum of Brønsted acids of medium 
strength, the concentration and strength of the conjugated base such as 117 is suitable to 
deprotonate type-118 intermediates and hence cause racemization. This base-generation 
hypothesis is supported by the mechanistic work of Bergman and Toste on the phosphine-
catalyzed hydration and hydroalkylation of activated olefins.[133] 
 
  50
PPh3 +
OTosHN
OH
O
+
H OTosHN H
PPh3
OTosHN H
PPh3
H
− PPh3, phenol
OH NH
Tos
X X
XX
53 (S)-106 (X = Br)(S)-114 (X = NO2)
115 (X = Br)
116 (X = NO2)
111
117118 (X = Br)119 (X = NO2)
(R)-106 (X = Br)
(R)-114 (X = NO2)
53 111
 
 
Scheme 45. Potential racemization pathway involving phenol (111) /phenolate (117). 
 
The stability of the stereocenter of the product upon treatment with successful bifunctional 
catalysts like Shi’s phosphinyl-BINOL catalyst 88 indicates that the spatial arrangement of a 
bifunctional catalytic system is of major importance for the prevention of racemization 
(Scheme 46). A possible explanation for this phenomenon involves the intramolecular 
coordination of the enolate-oxygen by the phenolic OH group of catalyst 88. This may form a 
stabile adduct like 120/121 and thereby prevent the formation of the conjugated phenolate 
base which is postulated as a key intermediate in the racemization of the aza-BH product. 
 
PPh2 +
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120(X = Br)
121 (X = NO2)
HO
*
O
H
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Scheme 46. Model for the prevention of racemization with Shi’s catalyst 88 (compound 88 is 
represented as HO^PPh2). 
 
In absence of a Brønsted acid, an imine-mediated racemization takes place (Table 2, 
entry 4). A possible mechanism, which explains this racemization pathway, might involve a 
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hemi-aminal intermediate. Similar intermediates have been suggested by McQuade and co-
workers in the so-called HEMI-ACETAL MECHANISM for the BH reaction. Furthermore, the 
occurrence of cyclic products in the aza-BH reaction was explained by the formation of hemi-
aminals (page 25). There is, however, not enough direct experimental evidence available to 
unequivocally identify such kind of mechanism at the present stage. 
 
3.1.4. Chirality Transfer  
 
Representative for the chirality transfer models that are reported in literature is the hypothesis 
by Shi and co-workers involving catalyst 88.[48b]  This model is depicted in Scheme 47. 
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Scheme 47. Model by Shi and co-workers for the chirality transfer in the aza-BH reaction. 
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They postulated that compound 88 acts as a bifunctional chiral catalyst in the aza-BH 
reaction. The phosphine atom acts as a Lewis base and the phenolic OH group as a Brønsted 
acid. The Lewis basic moiety initiates the aza-BH reaction whereas the Brønsted acid 
stabilizes both intermediates of the catalytic cycle (122 and 124/125) through hydrogen 
bonding to the enolate-oxygen and imine-nitrogen, respectively. During the Mannich-type 
coupling step, 4 diastereoisomers can in principle be formed. In Shi’s model, only the (R,S,R)- 
and the (R,R,R)-diastereoisomers 124 and 125 are considered.  Because of the steric 
repulsions between the C(O)Me group with the aromatic group and the aromatic group with 
the two phenyl groups at phosphorus in intermediate 125, the authors suggest that the 
activation energy for the pathway through 125’ is higher than through 124’.  This kinetic 
selection implements the necessity of a reversible Mannich-type coupling. In accordance with 
the model reported by Aggarwal and Lloyd-Jones, the reaction would “filter” through the 
elimination pathway.[71] 
 Shi’s model, however, comprehends several ambiguities. The first ambiguity involves 
the consideration of only two of four diastereoisomeric intermediates that may result from the 
Mannich-type coupling of enolate 122 and imine 123. This selection is not motivated in their 
report. Therefore, the relative energies of all four diastereoisomers that may result from the 
Mannich type coupling of N-benzylidene-4-methylbenzenesulfonamide (67) with enolate 122 
were determined in a computational study using DFT calculations in the present work.[134],[135] 
The results are shown in Figure 9. 
The (R,S,R)- and (R,R,S)-diasteroisomers were significantly higher in energy (6.2 and 
8.3 kcal⋅mol−1, respectively) relative to the lowest energy conformer of the (R,S,S)-form. The 
energy of the (R,R,R)-diastereoisomer, however, was only 1.2 kcal⋅mol−1 above the energy of 
the (R,S,S)-form. Accordingly we re-optimized the structures of the (R,S,S)- and (R,R,R)-
diastereoisomers using the larger TZVP basis set by Ahlrichs and co-workers.[136a] For these 
optimizations (Turbomole 5.7)[136b] the BP86[136c,d] functional was used (Turbomole 5.7 was 
used simply for efficiency considerations). Again the energy difference between (R,S,S)- and 
(R,R,R)-form was small (0.5 kcal⋅mol−1), now with the (R,R,R)-diastereoisomer being the 
more stable compound. 
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(R,S,S)  0.0 (R,R,R)  1.2
(R,S,R)  6.2 (R,R,S)  8.3  
 
Figure 9. Calculated structures of all four diastereoisomers (relative energies in kcal⋅mol−1).  
 
Following Shi’s explanation, in which the stability of the intermediates correlates directly 
with the relative energies of the transition states that lead to elimination of the aza-BH 
product, the (R)-product should be formed in a fairly low enantiomeric excess of about 
48%.[137] The observed enantioselection for this reaction, however, corresponded to an 
enantiomeric excess of 83% (S) at −30°C.[48b]  
 A further requirement for the validity of Shi’s model is the reversibility of the 
Mannich-type coupling. For the model system PPh3 (53)/phenol (111), no products from 
cross-Mannich reactions were observed under turn-over conditions. Therefore, it is unlikely 
that the Mannich coupling is reversible with Shi’s catalyst 88. Consequently, a model in 
which the enantioselection is fully determined in the Mannich type coupling step seems a 
more plausible alternative. 
 Furthermore, it is noteworthy that the phenolic OH group of catalyst 88 tends to 
coordinate to the SO oxygen rather than to the imine nitrogen in the calculated structures 
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depicted in Figure 9. This illustrates that the activating group on the imine might play a vital 
role in the chirality transfer from the catalyst to the aza-BH product. 
 
3.1.5. Implications for Asymmetric Catalysis 
 
All successful chiral catalysts to date contain two catalytic moieties: a Lewis basic and a 
Brønsted acidic one. The Brønsted acidic co-catalyst is necessary to obtain an effective 
system with regard to the catalyst’s activity and selectivity. In contrast to the results obtained 
by Aggarwal and Lloyd-Jones for the BH reaction, there is no evidence for autocatalysis. 
Competitive catalysis by the reaction product can therefore be ruled out. The work of Sasai 
and Shi shows that a suitable positioning of both catalytically active groups is necessary to 
obtain a high enantiomeric excess. The Mannich-type coupling can lead to four 
diastereoisomers. There are two scenarios to explain the enantioselectivity of the reaction:  
 
(1) All four diastereoisomers are formed, and because of the spatial arrangement only one 
undergoes a fast proton transfer. The others then revert back to the starting materials and 
the proton transfer serves as a selective “filter” for the reaction.  
 
(2) A second pathway involves the selective formation of one (or two) diastereoisomers 
leading directly to the product with the desired configuration.  
 
The first route is dependent on the reversibility of the C-C coupling step – the Mannich 
reaction. In the cross-Mannich experiments performed in this mechanistic study no cross-
Mannich products were observed which makes this explanation very unlikely.  
Considering the limitations of the model, in which the proton migration step 
determines the enantioselectivity of the reaction, it seems more likely that the enantioselection 
takes place in the C-C coupling step. This, however, could not yet be validated in 
experimental or theoretical studies.  
A potential reason for the small success rate in the design of chiral catalysts for the 
aza-BH reaction may lie in the lability of the product’s stereocenter. The results obtained with 
Shi’s catalyst 88 in comparison to the model system triphenylphosphine (53)/phenol (111) 
show that the spatial arrangement of a bifunctional catalyst is not only important for an 
efficient transfer of the chiral information but also for the prevention of racemization.  
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3.2. Design of New Catalytic Systems for the Asymmetric Aza-Baylis-Hillman Reaction   
 
3.2.1. QUINAP Derivatives 
 
QUINAP (127), a powerful and versatile ligand for asymmetric transition-metal catalysis, was 
developed by Brown and co-workers in 1993.[138]  This axially chiral aminophosphine has 
been successfully applied as P,N-ligand in Rh-catalyzed hydroboration and 
hydroboration/amination reactions [139],[140] and Pd-catalyzed allylic substitutions.[141] 
Since the binaphthyl backbone has proven to be a valuable lead structure for chiral 
bifunctional organocatalysts for the aza-BH reaction,[48] the use of QUINAP (127) and 
QUINAP-type derivatives seemed interesting. The structures depicted in Scheme 48 − (R)-
QUINAP (127), rac-1-(2-diphenylphosphanylnaphthalen-1-yl)isoquinoline-3-carboxylic acid 
(128) and 1-(2-diphenylphosphanylnaphthalen-1-yl)isoquinoline-3-carboxylic acid (3-
hydroxy-2-phenylpropyl)amide (129) − were tested as catalysts in the aza-BH reaction of the 
aromatic aldimines 67 (unsubstituted), 102 (m-F) and 113 (p-NO2)  with MVK (37), methyl 
acrylate (42) and cyclopentenone (130) as Michael acceptors (Scheme 49). 
 
N
PPh2
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N
COOH
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O
H
N OH
Ph
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Scheme 48. QUINAP-derivatives as catalysts for the aza-BH reaction. 
 
A starting concentration of 0.125 mol imine per l THF was applied. The reaction was 
performed on a 2 ml scale. Conversion (conv.) was determined via 1H- and/or 19F NMR 
spectroscopy, the enantiomeric excess of the reaction product was analyzed via chiral HPLC 
(only in case of conv. > 15%). 
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Scheme 49. Aza-BH reaction with QUINAP-derivatives. 
 
In a first set of experiments, the scope of the catalysts towards different Michael acceptors 
was tested. The results are depicted in Table 3. 
 
Table 3. Screening of different Michael acceptors. 
 
entry  imine alkene catalyst catalyst 
[mol-%] 
alkene 
[eq] 
t / h conv. 
[%] 
1 113 42 128 10 1.2 24 0 
2 113 42 129 10 1.2 24 0 
3 113 130 128 10 1.2 24 0 
4 113 130 129 10 1.2 24 0 
5 113 37 128 10 1.2 24 11 
6 113 37 129 10 1.2 24 7 
 
Reaction conditions: 38.0 mg (0.125 mmol, 1.00 eq) imine 113, 0.150 mmol (1.20 eq) alkene, 
0.0125 mmol (0.10 eq) catalyst, 2.0 ml (16.0 ml⋅mmol−1 113) THF, r.t., t = 24 h.  
 
These results showed that the QUINAP-derivatives 128 and 129 displayed a low activity in 
comparison to similar bifunctional catalysts like 88.[48b] Furthermore, the scope of these 
catalysts towards the activated alkenes was rather limited. The only system that displayed any 
activity was obtained with MVK as Michael acceptor. 
 To verify whether the low activity of 128 and 129 in the aza-BH reaction was intrinsic 
or due to catalyst deactivation, the reaction time was prolonged. The results for the coupling 
of imine 102 with the activated alkenes 37, 42 and 130 are shown in Table 4. 
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Table 4. Coupling of imine 102 with the activated alkenes MVK (37), methyl acrylate (42) 
and cyclopentenone (130), catalyzed by 129. 
 
entry  imine alkene catalyst catalyst 
[mol-%] 
alkene 
[eq] 
t / h conv. 
[%] 
ee 
[%] 
1 102 37 129 10 1.2 24 10 n.d. 
2 102 37 129 10 1.2 67.5 24 6.0 
3 102 37 129 20 5.0 24 50 6.0 
4 102 42 129 20 5.0 24 0 n.d. 
5 102 130 129 20 5.0 24 0 n.d. 
 
Reaction conditions: 69.4 mg (0.250 mmol, 1.00 eq) imine 102, 2.0 ml (8.0 ml⋅mmol−1 102) 
THF, r.t.  
 
These results show, that the catalyst was not completely deactivated after 24 h in the coupling 
of imine 102 with MVK (37) (entry 1, 2). Furthermore, a reasonable yield within 24 h could 
be achieved by a 4-fold increase of the amount of MVK (37) and a 2-fold increase of the 
amount of catalyst 129 (entry 3). Under these reaction conditions, however, catalyst 129 still 
showed no activity in the coupling of imine 102 with methyl acrylate (42) and cyclopentenone 
(130) (entry 4, 5). The enantioselectivity in the aza-BH reaction of imine 102 with MVK (37) 
was very poor and independent from the reaction time, the amount of catalyst, and Michael 
acceptor (entry 2, 3). 
To determine the relative activity and selectivity of all three catalysts, they were tested 
in the coupling of the imines 67 and 102 with MVK (37) under the reaction conditions, 
displayed in entry 3 of Table 4 (20 mol-% catalyst, 5.0 eq MVK). The results are shown in 
Table 5.  
These results showed that the activity of all three catalysts was rather low in 
comparison to similar bifunctional catalysts reported in literature.[48b] The best results with 
respect to catalytic activity were obtained with catalyst 128, the QUINAP-derivative with 
carboxylic acid group (128 > 129 > 127). The enantioselectivity that was obtained with the 
enantiopure catalysts 127 and 129 was very poor.  
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Table 5. Coupling of the imines 67 and 102 with MVK (37). 
 
entry imine catalyst Conv. [%] ee [%] 
1 67 127 12 rac 
2 67 128 47 - 
3 67 129 34 rac 
4 102 127 43 rac 
5 102 128 94 - 
6 102 129 50 6.0 
 
Reaction conditions: 0.250 mmol (1.00 eq) imine, 104.1 μl (1.250 mmol, 5.00 eq) MVK, 
0.050 mmol (0.20 eq) catalyst, 2.0 ml (8.0 ml⋅mmol−1 102) THF, r.t., 24 h.  
 
QUINAP does not contain an acidic moiety which can serve as co-catalyst for the aza-
BH reaction. Therefore, its low activity and enantioselectivity was not unexpected. By 
protonation of the quinoline-nitrogen, however, one would create a side group with a pKA 
similar to the pKA of phenol.[132] This would result in a catalyst, which is structurally related to 
Shi’s catalyst 88 and contains an acidic group with a pKA value similar to that of the phenolic-
OH group in 88.  Selective N-protonation of QUINAP (127) requires a Brønsted acid of 
medium strength. Strong Brønsted acids would deactivate the catalyst by protonation of the 
phosphino-group. Phenol (111) was chosen as Brønsted acid to generate the protonated 
QUINAP derivative in situ. The results are shown in Table 6. 
 
Table 6. Catalysis results with N-protonated QUINAP. 
 
entry imine catalyst Conv. [%] ee [%] 
1 67 127 12 rac 
2 67 127/111 35 rac 
3 102 127 43 rac 
4 102 127/111 88 rac 
 
Reaction conditions: 0.250 mmol (1.00 eq) imine, 104.1 μl (1.250 mmol, 5.00 eq) MVK, 
0.050 mmol catalyst (0.20 eq), 2 ml THF (8.0 ml⋅mmol−1 imine), r.t., 24 h. 
 
These results show that the activity of the catalyst increased significantly through addition of 
phenol (111) (entry 2, 4). The enantioselectivity, however, remained unchanged. 
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Although the activity and selectivity of these catalysts in the asymmetric aza-BH reaction was 
rather low, catalyst 128 could be used to intercept and characterize the intermediates of the 
phosphine-catalyzed aza-BH reaction for the first time (Scheme 50). 
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Scheme 50. The intermediates of the aza-BH reaction of imine 67 with MVK (37), catalyzed 
by QUINAP-derivative 128, in their protonated forms.  
 
 The first intermediate 133 results from a Michael type addition of the phosphine 
catalyst 128 to MVK (37). It could be intercepted in its protonated form (131) by addition of 
one equivalent of MVK (37) to a solution of catalyst 128 in CDCl3. The solution was stirred 
for 5 min at room temperature (Scheme 51). 
 
N
COOH
P
O
Ph Ph
133
N
COOH
PPh2
+ O
CDCl3, r.t., 5 min N
CO2−
P
O
Ph Ph
13137128  
 
Scheme 51. Interception of intermediate 133 in its protonated form (131).  
 
The protonated intermediate 131 was identified via multinuclear NMR- and high-resolution 
electrospray ionization mass spectroscopy (HR-ESI-MS). The 1H- and 31P NMR spectra are 
shown in Figure 10 and 11, respectively. 
 In the 1H NMR spectrum, the signals which correspond to the PCH2CH2 moiety were 
positioned between 3 and 5 ppm. Due to the chirality of catalyst 128 this moiety consisted of 
four protons in a 1:1:1:1 ratio.  
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Figure 10. 1H NMR spectrum of the reaction mixture containing intermediate 131. 
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Figure 11. 31P NMR spectrum of the reaction mixture containing intermediate 131. 
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The 31P signal of catalyst 128 at −13.7 ppm disappeared nearly completely. This 
demonstrated that catalyst 128 was almost completely converted to intermediate 131 (δ = 26.9 
ppm) under these reaction conditions. The remaining signal at 30.3 ppm corresponds to the 
phosphine oxide (134). 
The second intermediate (135), which results from a Mannich-type coupling of enolate 
133 with imine 67 could in principle be obtained both from the side of the starting materials 
and the reaction product. In systems with Brønsted acidic co-catalysts, however, the Mannich-
type coupling is the RDS. This implied that intermediate 135 would be formed after the RDS 
and therefore most likely be difficult to intercept. Thus, starting from the reaction product in a 
Michael-type reaction seemed more promising (Scheme 52). 
 
N
COOH
PPh2
128
ONHTos
N
COOH
P
O
Ph Ph
Ph
N
H
Tos
132
+
N
COOH
P
O
Ph Ph
Ph
N
H
Tos
135
H+
77
 
 
Scheme 52. Interception of intermediate 135 in its protonated form (132). 
 
For this reaction diphenylacetic acid was used as an additional proton source. The resulting 
reaction mixture contained only a small amount of 132 (about 13% of the P-containing 
species in solution). A characterization of 132, however, was possible via multinuclear NMR 
and HR-ESI-MS. The (1H, 31P)-correlation spectrum, the 1H spectrum and the 31P spectrum 
are shown in Figure 12, 13 and 14, respectively.  
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Figure 12. (1H, 31P)-correlation spectrum of the reaction mixture with 132. 
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Figure 13. 1H NMR spectrum of the reaction mixture with 132 (x = from (1H,31P)-correlation 
spectrum, o = from (1H,1H)-COSY and TOCSY). 
 
The signals marked with “x” were unambiguously assigned to the aliphatic protons of 
intermediate 132 in α- and β-position to the P-atom via (1H, 31P)-correlation. The fourth 
signal, marked with “o”, was assigned to the proton in γ-position through (1H, 1H)-correlation 
and TOCSY.  
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Figure 14. 31P NMR spectrum of the reaction mixture with 132. 
 
This was the first time that both intermediates of the phosphine-catalyzed aza-BH reaction 
were intercepted and structurally characterized. The first intermediate (type-131) was also 
obtained for various other phosphine catalysts in combination with MVK (37) and an external 
acid source (Table 7). Conv. (31P) is the conversion of the starting phosphine to the 
corresponding adduct (type-131), derived from the 31P NMR spectra. 
 
Table 7. Intercepted first intermediate of the aza-BH reaction. 
 
entry phosphine acid acid:alkene δ 31P (phosph./add.) 
[ppm] 
Conv. 
(31P) 
[%] 
1 53 malic acid 1.0 -5.4 / 25.5 95.0 
2 127 diphenyl acetic acid 1.0 -14.1 / 26.4 52.6 
3 128 - 0.0 -13.7 /26.9 64.3 
4 129 diphenyl acetic acid 1.0 -13.4 /26.0 32.3 
 
Reaction conditions: 1.00 eq phosphine, 1.00 eq MVK, 1.00 eq diphenylacetic acid, NMR 
solvent, r.t., 5 h.  
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3.2.2. Other phosphinocarboxylic acids  
 
As a model system to verify the catalytic potential of phosphinocarboxylic acids with various 
distances between both functionalities in the aza-BH reaction, 2-, 3- and 4-
diphenylphosphanyl benzoic acid were tested as catalysts (Scheme 53). 
 
COOH
Ph2P
COOH
PPh2
COOH
PPh2
PPh3
COOH
+
136 137 138 53 139
0% 70% 38% 86%  
 
Scheme 53. Diphenylphosphanyl benzoic acids as catalysts for the aza-BH reaction of imine 
102 (m-F) with MVK (37). Reaction conditions: 69.33 mg (0.250 mmol, 1.00 eq) imine 102, 
7.66 mg (0.0250 mmol, 0.10 eq) diphenylphosphanyl benzoic acid, 25.0 μl (0.300 mmol, 1.20 
eq) MVK, 2.0 ml (8.0 ml⋅mmol−1) THF, r.t., 24 h. 
 
These results clearly indicated that the activity of the catalyst was dependent on its geometry: 
compound 136, in which both catalytic moieties are positioned ortho to each other, was 
inactive. The “meta-catalyst” 137 was the most active compound albeit its catalytic activity is 
still lower than the activity of the 1:1 system PPh3 (53)/benzoic acid (139). This results in 
following trend in activity: 53/139 > 137 > 138 > 136.   
 As chiral phosphinocarboxylic acid, (R,S)-2-diphenylphosphanyl-cyclohexane-
carboxylic acid (140) was tested as catalyst for the coupling of imine 105 with MVK (37) 
(Scheme 54). 
Br
N Tos O
+
Br
NH OTos
COOH
PPh2
(10 mol-%)
r.t., THF, 24 h
105 37
140
106
86%
rac  
Scheme 54. Coupling of imine 105 with MVK (37), catalyzed by phosphinocarboxylic acid 
140. Reaction conditions: 51.0 mg (0.125 mmol, 1.00 eq) imine 105, 12.5 μl (0.150 mmol, 
1.20 eq) MVK, 3.90 mg (0.0125 mmol, 0.10 eq) catalyst 140, 1.0 ml (8.0 ml⋅mmol−1) THF, 
r.t., 24 h. 
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Although the activity of the system is higher than the activity of Shi’s catalyst 88 under the 
same conditions (60% yield), the product is obtained as racemate.[48b] Racemization of 
enantiomerically enriched aza-BH product 106 under the influence of catalyst 140 was 
excluded in the corresponding control experiment. Consequently, the reason for the formation 
of racemic product was the low intrinsic enantioselectivity of catalyst 140. 
 
3.2.3. Chiral Brønsted Acids 
 
The use of a combined system Lewis base/chiral Brønsted acid proved to be a valuable 
strategy for obtaining high enantioselectivities in the BH- and aza-BH reaction (cf. Jacobsen’s 
urea-catalysts, Schaus’ BINOL system), although the risk of subsequent racemization of the 
aza-BH product is high as compared to catalysts that combine both functionalities suitably 
positioned in one chiral compound.[38], [40]  
 As Brønsted acids, chiral alcohols were tested as co-catalysts in the PPh3-catalyzed 
coupling of imine 105 (p-Br) with MVK (37) (Scheme 55). In all experiments, the 
enantiomeric excess of the corresponding reaction product was very poor. The best result (ee 
= 11%) was obtained with (R)-BINOL as additive. 
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Scheme 55. Chiral co-catalysts for the PPh3-catalyzed aza-BH coupling of imine 105 with 
MVK (37). Reaction conditions: 51.0 mg (0.125 mol, 1.00 eq) imine 105, 12.5 μl (0.150 
mmol, 1.20 eq) MVK, 3.28 mg (0.0125 mmol, 0.10 eq) PPh3, 0.0375 mmol (0.30 eq) 
Brønsted acid, 1.0 ml (8.0 ml⋅mmol−1 105) THF, r.t., 24 h. 
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3.2.4. Chiral Aminoalcohols 
 
3.2.4.1. Synthesis 
 
 
In accordance with previous reports in literature (page 29) [38], [88], [114]-[116] and the mechanistic 
investigations described above, aminoalcohols of type-145 are potential bifunctional 
asymmetric catalysts for the aza-BH reaction. Besides a Lewis basic tertiary amino group, 
they contain an alcohol moiety as co-catalyst. Kinetic- and racemization studies with weak 
acids like alcohols in the phosphine-catalyzed aza-BH reaction showed that they are able to 
serve as co-catalyst – methanol causes rate acceleration by a factor of 3.7 – but that their 
acidic strength is insufficient to induce racemization of the reaction product. An efficient 
access to this class of aminoalcohols must be straightforward and substitution diversity should 
be possible without major changes of the synthetic route. One flexible strategy to obtain this 
type of aminoalcohols is shown in Scheme 56. 
This strategy involves an ex-chiral-pool synthesis starting from the chiral building 
block hydroxyproline. In step A the acid group would be protected by esterification, followed 
by protection of the aminogroup of aminoester 152 in step B. For step F it is required that the 
aminogroup carries an electron donating group. This should be considered in the choice of an 
appropriate protecting group R’. In step C, the OH group of 151 should be protected, followed 
by a reduction of the ester moiety in step D. The OH group of the corresponding vic-
aminoalcohol 149 would then be transformed into a leaving group (e.g. via mesylation). In an 
intramolecular SN2 reaction followed by a ring opening of the corresponding aziridinium-ion 
147, compound 146 would be formed as a product of ring expansion. Deprotection of the OH 
group would then lead to the desired class of aminoalcohols 145. 
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Scheme 56. Strategy for the synthesis of aminoalcohol 145. 
 
For the synthesis, trans-4-hydroxy-L-proline (154) was used as starting material. In the first 
step, compound 154 was converted into the corresponding methyl ester. This was isolated in 
form of its hydrochloride salt 155. 
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Scheme 57. Synthesis of the methylester 155. 
 
According to a procedure reported by Enders and co-workers, 155 was prepared by addition 
of trans-4-hydroxy-L-proline to a solution of thionylchloride in methanol at 0°C.[142] After 
warming to room temperature, the mixture was stirred for 24 h. Then, the excess SOCl2 and 
methanol was removed in vacuo.  Subsequently compound 155 was crystallized from a 
mixture of methanol and diethylether and isolated in quantitative yield. 
 The second step consisted of protection of the amino group of 155 via benzoylation 
(Scheme 58).[142] 155 was dissolved in dichlormethane at room temperature and treated with a 
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large excess of triethylamine. After stirring the mixture for 1.5 h at room temperature, DMAP 
and benzoylchloride were added. The resulting reaction mixture was stirred overnight. 
Precipitation from dichloromethane/pentane yielded compound 156 as a colorless precipitate 
in 80% yield. 
 
 
N
H2
O
HO
O Cl
-
NEt3, DMAP, PhC(O)Cl
DCM, r.t., 14 h
N
O
HO
O
O
155 156
80%  
 
Scheme 58. Benzoyl-protection of the amino group in 155. 
 
 In the third step, 156 was converted into the corresponding tert-butyldimethylsilyl 
(TBS) ether 157 (Scheme 59).[142] 
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Scheme 59. Conversion of 156 into its corresponding TBS-ether 157. 
 
Amide 156 and imidazole were dissolved in DMF and stirred at room temperature for 3 h. 
Then, a solution of tert-butyldimethylsilyl chloride (TBSCl) in toluene was added dropwise 
and the resulting mixture was stirred at room temperature for 40 h. After removal of the 
volatiles in vacuo, the residue was taken up in ether and underwent a standard organic 
workup. The resulting organic residue was recrystallized from dichloromethane/pentane. 
Compound 157 was obtained in quantitative yield in form of colorless crystals. 
 In the next step, the ester moiety was reduced to the corresponding primary alcohol 
(Scheme 60). Under the employed conditions, the benzoyl group was reduced as well.[142] 
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Scheme 60. Reduction of 157 with lithium aluminiumhydride (LAH). 
 
To a suspension of LAH in THF, a solution of ester 157 in THF was carefully added. The 
resulting mixture was heated under reflux for approximately 1.5 h. After hydrolysis with 20-
% aqueous KOH solution and standard organic workup, the compound was obtained as 
colorless oil in quantitative yield. Aminoalcohol 158 was used without further purification. 
 The vic-aminoalcohol 158 was treated with methanesulfonyl chloride (MsCl) to 
convert the OH group to an appropriate leaving group for nucleophilic substitution (Scheme 
61). 
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Scheme 61. Reaction of 158 with MsCl. 
 
MsCl and triethylamine were added to a solution of aminoalcohol 158 in THF at 0°C. After 
0.5 h, the reaction mixture was heated to reflux for 12 h. Then, the suspension was cooled to 
room temperature and poured into an aqueous 2.5 M-NaOH solution. After standard organic 
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workup, the resulting oil was purified via column chromatography and isolated as yellow oil 
in 57% yield. The NMR spectra of the resulting compound provide proof for the formation of 
one single diastereoisomer. The absolute configuration was assigned via NOESY (Figure 15). 
The NOESY spectrum was recorded at −40°C in CDCl3 and displayed a clear NOE contact 
between the Si-CH3 group and the proton in α-position to the Cl-atom. This, in combination 
with the fixed R-configuration for the stereocenter adjacent to the silyl group, unambiguously 
proved the (R,R)-configuration of compound 159. 
 NMR-, GC- and GC-MS analysis proved that the intermediate aziridinium ion was 
solely attacked by chloride anions. The corresponding amino mesylate (159, Cl = OMs) could 
not be detected. Similar results were obtained by the group of Cossy.[143] They postulated the 
involvement of a tight ion pair to explain this chemoselectivity. 
In the last step, the TBS-ether was cleaved according to standard procedure with tetra-
n-butyl ammonium fluoride (TBAF) in THF (Scheme 62).[144]  
 
TBAF
DCM, r.t., 14 hN
ClOSi
159
N
ClHO
160
81%  
 
Scheme 62. Cleavage of the TBS-ether 159. 
 
TBAF was added to a solution of TBS-ether 159 in dichloromethane. The mixture was stirred 
at room temperature overnight. After standard organic workup, the resulting colourless solid 
was purified via column chromatography. Aminoalcohol 160 was isolated as a colourless 
solid in 81% yield.  
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Figure 15. NOESY spectrum of compound 159 in CDCl3 at −40°C.
 In conclusion, vic-aminoalcohol 160 could be synthesized in a 6 step-synthesis with an 
overall yield of 37%. In principle, all four diastereoisomers of this compound can be 
selectively produced starting from hydroxyproline precursors with different stereochemistry.  
 
3.2.4.2. Catalysis  
 
Both the TBS protected vic-aminoalcohol 159 and the deprotected aminoalcohol 160 were 
tested as catalysts for the aza-BH coupling of imine 113 (p-NO2) with MVK (37) in THF at 
room temperature. With a catalyst loading of 10 mol-% and a ratio of MVK : imine = 1.2 : 1, 
no conversion was observed within 24 h.  Several parameters were varied to increase the 
system’s reactivity: the catalyst loading was increased up to a stoichiometric amount (100 
mol-%), the ratio MVK : imine was varied in the range of 1.2 - 5.0, the temperature was 
increased up to 60°C and the substitution pattern (X = p-NO2, m-F, p-Br, p-Me) of the imine 
was varied. In all cases, no conversion could be detected. A possible reason for this 
unexpected result could be the nucleophilicity of the amino group. In case of non-sufficient 
nucleophilicity, the catalyst cannot initiate the Michael addition as first step of the catalytic 
cycle and remains unactive.  
 A possible strategy to overcome this problem involves the introduction of different 
protecting groups at the Nitrogen atom. It was, however, decided to focuss on a different 
strategy to create a new enantioselective system for the aza-BH reaction – the design and 
application of a chiral reaction medium. In future investigations, vic-aminoalcohol 160 as well 
as its precursor 159 may serve as chiral backbone chiral for the formation of catalysts for 
other organocatalytic processes as well as ligands for homogeneous transition metal catalysis. 
 
3.2.5. Chiral Solvents 
 
ILs, often referred to as DESIGNER SOLVENTS, offer the possibility of adapting their solvent 
properties to a given chemical need through structural variations of one or both ions.[145] The 
investigations on the mechanism of the aza-BH reaction provided useful information for the 
design of a chiral solvent for this process. It was shown that a bifunctional interaction of the 
catalyst with the zwitterionic reaction intermediates (transition states) is beneficial for 
obtaining high enantioselectivity and preventing subsequent racemization of the reaction 
product. In conventional systems, this can be achieved by incorporating both the nucleophilic 
catalyst and the Brønsted acidic co-catalyst in one chiral molecule. ILs, however, might offer 
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the possibility of obtaining a bidentate interaction by incorporating the acidic center in the 
chiral solvent, allowing simple monofunctional achiral nucleophiles to be used as catalysts in 
the enantioselective aza-BH reaction (Scheme 63). A long and complicated synthesis of a 
suitable bidentate catalyst can then be avoided. 
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Scheme 63. Illustration for a possible bifunctional interaction of the first zwitterionic 3-
phosphoniumenolate intermediate of the aza-BH reaction with the anion of an anion-chiral IL 
containing a hydrogen bond donor. 
 
 Apart from the structural requirements elucidated above, the chiral reaction 
medium has to meet some general stipulations. It should be cheap, easy to prepare and stable 
under reaction conditions. Furthermore, the chiral building block should preferably be 
available in both enantiomeric forms to obtain a selective access to both optical antipodes of 
the desired product. These considerations led to the application of an anion-chiral IL derived 
from malic acid (162). In a straight-forward ex-chiral-pool synthesis developed by Rolf 
Gausepohl, the desired reaction medium was obtained as a colorless room-temperature IL 
(Scheme 64).[146] 
The first step involved the preparation of the corresponding sodium dimalatoborate 
salt (165) by stirring an aqueous solution of boric acid (164), sodium hydroxide (163) and L-
(−)-malic acid (162) in an open flask at 100°C. After complete evaporation (within 
approximately 4 h), sodium dimalatoborate (165) was isolated as a colourless salt in 
quantitative yield. The dimalatoborate anion contained exclusively five-membered rings and 
consisted of a nearly 1:1-mixture of diastereoisomers. This resulted from the fixed chirality at 
the asymmetric carbon atoms and the labile chirality at the boron center of this spiro-type 
compound. Configurational lability of orthoborates has been described earlier in literature by 
Boeseken and Mijs.[147]  
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Scheme 64. Two-step synthesis of methyltrioctyl ammonium dimalatoborate (166) (only the 
(S,S,S)-diastereoisomer is shown).  
 
The second step involved a cation-exchange replacing the sodium ion with a cation 
typically used for the formation of ILs: the methyltrioctyl ammonium ion. The reaction took 
place with Aliquat 336® (≡ methyltrioctyl ammonium chloride, 167) in acetone. Under the 
precipitation of sodium chloride the desired compound 166 was isolated as a hygroscopic and 
viscous colorless liquid (C = 72 ± 2%, determined from 1H NMR spectroscopy).[148] 
The aza-BH reaction between MVK (37) and the aromatic tosyl-aldimines 105, 168 
and 113 was performed in this new reaction medium (166) (Scheme 65). 
 
N Tos ONHTos
+
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168 (X = CH3)
113 (X = NO2)
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114 (X = NO2)  
 
Scheme 65. Reaction between the aromatic tosylaldimines 67, 168 and 113 and MVK (37) in 
methyl trioctylammonium dimalatoborate (166) (R = C6H5, o-CH3C6H4, etc). 
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As nucleophilic catalysts the commercially available, achiral triarylphosphines PPh3, P(o-
tolyl)3 and (C6F5)PPh2 were applied. The best results were obtained with imine 105 (X = Br) 
and triphenylphosphine (53) as catalyst. Using 1.2 eq of MVK (37) and 10 mol-% of 
phosphine 53, the corresponding chiral allylic amine (R)-106 (X = Br) was obtained with a 
reasonable conversion and a high enantiomeric excess.[149]  In a series of four independent 
experiments using various batches of IL 166, conversion varied between 34-39% and the 
enantioselectivity ranged from 71-84% ee. The highest ee of 84% observed in these 
experiments corresponds to an enantiomeric ratio of er = 11.5 and hence an energetic 
differentiation of ΔΔG‡ = 6.05 kJ·mol-1 for the formation of the two enantiomers.[137] So far, 
this is the highest level of enantioselectivity obtained with a chiral solvent as the sole source 
of chirality. It exceeds the asymmetric induction reported in the work by Loupy and co-
workers for the BH reaction of benzaldehyde with methyl acrylate by a factor of 3.2.[125]  
 Although a variation of the achiral catalyst (PPh3, P(o-tolyl)3 and (C6F5)PPh2) did not 
cause a significant change in enantioselectivity, conversion dropped with a decrease in 
nucleophilicity of the phosphine (P(o-tolyl)3 ≈ PPh3 > (C6F5)PPh2) (Table 8). 
 
Table 8. Different phosphine catalysts for the coupling of imine 105 (X = Br) with MVK (37) 
in IL 166. 
 
entry phosphine conv. [%] ee [%] 
1 PPh3 37 77 (R) 
2 P(o-tol)3 35 74 (R) 
3 (C6F5)PPh2 9 71 (R) 
 
Reaction conditions: 51.0 mg (0.125 mol, 1.00 eq) imine 105, 12.5 μl (0.l50 mmol, 1.20 eq) 
MVK, 0.0125 mmol (0.10 eq) phosphine, 1.0 ml (8.0 ml⋅mmol−1 105) IL 166, r.t., 24 h. 
 
In contrast, the influence of the p-substituent X of the imine on the enantioselectivity of the 
reaction is very pronounced. Although increasing the electron density of the aromatic imine 
by substituting the Br- for a Me group in the para-position caused no large difference in 
conversion (C = 30% after 24 h) and enantioselectivity (ee = 64% (R)), a strong decrease of 
the enantiomeric excess was observed upon introduction of the highly electron-withdrawing 
nitro moiety (ee = 10% (R)) (Table 9). 
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Table 9. Influence of the para-substituent X of the aromatic tosylaldimine on conversion and 
enantioselectivity. 
 
entry X conv. [%] ee [%] 
1 Br 37 77 (R) 
2 CH3 39 64 (R) 
3 NO2 38 10 (R) 
 
Reaction conditions: 0.125 mmol (1.00 eq) imine, 12.5 μl (0.l50 mmol, 1.20 eq) MVK, 3.28 
mg (0.0125 mmol, 0.10 eq) PPh3, 1.0 ml (8.0 ml⋅mmol−1 imine) IL 166, r.t., 24 h. 
 
Since the stability of the stereogenic center of the aza-BH product under turn-over 
conditions is likely to decrease with the introduction of electron-withdrawing groups, one of 
the possible explanations for the dramatic drop of the enantiomeric excess could be a 
subsequent racemization of the allylic amine 114 (X = NO2). A control experiment with the 
enantiomerically enriched reaction product 114 (X = NO2), however, excluded this possibility 
indicating that the dependence of the enantioselectivity on the nature of the substituent X is a 
reaction intrinsic phenomenon. A similar decrease in optical induction was described by Vo-
Thanh and co-workers for the mechanistically related BH reaction of p-nitrobenzaldehyde and 
methylacrylate in ephedrinium based cation-chiral ionic liquids.[125] They explained the drop 
in enantioselectivity by the formation of a hydrogen bond between the OH group of the chiral 
ion and the NO2 function of the substrate. 
 To investigate whether methyltrioctyl ammonium dimalatoborate (166) acts as a chiral 
additive rather than a chiral solvent, the MtOA-IL 166, its corresponding sodium salt 165 and 
L-malic acid (162) were tested as additives for the triphenylphosphine-catalyzed aza-BH 
reaction of imine 105 (X = Br) with MVK (37) in THF.  In all cases, racemic product (106, X 
= Br) was obtained in low conversions (Table 10). 
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Table 10. PPh3-catalyzed reaction of imine 105 and MVK (37) with malic acid-based chiral 
additives. 
 
entry additive conv. [%] ee [%] 
1 166 10 rac 
2 165 10 rac 
3 162 8 rac 
 
Reaction conditions: 51.0 mg (0.125 mmol, 1.00 eq) imine 105, 12.5 μl (0.l50 mmol, 1.20 eq) 
MVK, 3.28 mg (0.0125 mmol, 0.10 eq) PPh3, 0.0125 mmol (0.10 eq) additive, 1.0 ml (8.0 
ml⋅mmol−1) THF, r.t., 24 h.  
 
Consequently, neither the IL 166 nor any of its chiral precursors (165, 162) can be used as 
additive for the aza-BH reaction in conventional organic solvents, which clearly underlines 
the necessity of using the IL 166 as a solvent for this process. 
 In the discussion of the structural requirements for an ideal IL for the aza-BH reaction, 
the necessity of a hydrogen bond donor group in the anion of the solvent was postulated for a 
benificial interaction with the zwitterionic transition states of this reaction (vide supra). To 
validate this hypothesis, the structurally related anion-chiral ILs 170 and 171 without a 
hydrogen bond donor, prepared by Gausepohl in a procedure which is similar to the synthesis 
of 166, were tested.[145] The results obtained with these solvents in the PPh3-catalyzed aza-BH 
coupling of imine 67 (X = Br) with MVK (37) are depicted in Scheme 66. 
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Scheme 66. ILs containing chiral anions without a Brønsted acid group. Reaction conditions: 
51.0 mg (0.125 mol, 1.00 eq) imine 105, 12.5 μl (0.l50 mmol, 1.20 eq) MVK, 3.28 mg 
(0.0125 mmol, 0.10 eq) PPh3, 1.0 ml (8.0 ml⋅mmol−1 105) IL, r.t., 24 h. 
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Notably, the structurally related ILs 170 and 171 resulted in lower conversions (14% and 15% 
respectively) and formation of racemic product 106 (X = Br), which indicates the necessity of 
a Brønsted acidic moiety within the chiral ion. 
 In conclusion, it is shown that the strategy of applying chiral solvents in asymmetric 
synthesis can be a valuable strategy for obtaining chiral products with high enantioselectivity. 
With the specifically designed methyltrioctyl ammonium dimalatoborate IL 166, the aza-BH 
product 106 could be obtained with enantioselectivities up to 84% ee. 
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4. Summary and Outlook 
 
In this thesis, the rational development of a new enantioselective catalytic system for the 
asymmetric aza-BH reaction was described (Scheme 67). 
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Scheme 67. Aza-BH reaction of aromatic tosylaldimines with activated alkenes (X = H, p-
NO2, m-F etc; EWG = C(O)CH3, C(O)OCH3 etc). 
 
Since no mechanistic details on this reaction were known at the beginning of this work, an 
extensive study on the reaction mechanism was performed. This showed that the mechanistic 
details of the aza-BH reaction (see Scheme 29) did not fit into any of the existing mechanistic 
hypotheses for the related BH coupling. 
Detailed kinetic investigations via 19F NMR spectroscopy yielded rate law equations 
for the phosphine-catalyzed aza-BH reaction with and without Brønsted acidic co-catalysts 
(Scheme 68). 
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Scheme 68. Model reaction for kinetic study of the aza-BH reaction. 
 
 A comparison of these equations enabled the localization of the RDS in both cases: 
without co-catalyst, proton migration was involved in the RDS. Upon addition of a Brønsted 
acidic co-catalyst, this reaction step was considerably facilitated leading to a shift of the RDS 
to the Mannich-type coupling. Additionally, a set of Brønsted acids with pKA values in the 
range of 4-16 was screened. An evaluation of these results showed that a maximum in 
reaction rate was obtained with 3,5-bis(CF3)phenol (pKA ≈ 8) as additive, corresponding to a 
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14-fold rate enhancement as compared to the reaction without additive. Weakly acidic 
additives like methanol and water caused only a small rate enhancement; highly acidic 
additives like malic acid inhibited the reaction by protonation of the nucleophilic catalyst 
itself and the 3-phosphonium enolate. 
 In addition to this kinetic study, investigations towards the reversibility of the reaction 
were performed. Cross-Mannich experiments were carried out and evaluated. In none of these 
reactions, however, cross-over products were observed under turn-over conditions. This 
provided strong evidence for the irreversibility of this coupling step under these conditions.  
 Racemization experiments showed that the stereocenter of the aza-BH product was not 
always stable under turn-over conditions (Scheme 69). 
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Scheme 69. Racemization of the aza-BH product 106 under the influence of PPh3 and phenol.  
 
 When the reaction was performed in [D4]methanol, an H/D-exchange occurred at the 
stereogenic center. This demonstrated that the C-H bond at the stereogenic center was labile 
under turn-over conditions and that the racemization process is independent from the catalytic 
cycle. Further investigations on the rate of racemization and the influence of different reaction 
parameters displayed that either a Brønsted acid or remaining starting material (imine) in 
combination with the Lewis basic catalyst is necessary for product racemization. The results 
from more elaborate studies on the influence of the nature of the Brønsted acid on the rate of 
racemization provided information for the postulation of a mechanism, in which the 
conjugated base of the Brønsted acid played a vital role. 
 Information on the transfer of chirality from a bifunctional catalyst to the reaction 
product was obtained by studying Shi’s successful phosphine-BINOL catalyst 88 (see Scheme 
47).[48b] Shi’s mechanistic proposal was proven incomplete and amended. Furthermore, it was 
demonstrated via DFT calculations that bifunctional stabilization of the second intermediate 
of the aza-BH reaction through coordination of the phenolic OH group to the negatively 
charged imine nitrogen was very unlikely (see Figure 9).  In the calculated structures the OH 
group coordinated to the SO2 moiety of the activating tosylgroup. This might have wide-
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ranging consequences for the influence of the activating group on the enantioselectivity of the 
reaction. 
 The results from these mechanistic investigations provided useful information for the 
design of novel enantioselective systems. As potential chiral catalysts phosphinoarboxylic 
acids, chiral Brønsted acidic co-catalysts and QUINAP derivatives were tested. Although the 
obtained enantioselectivities were very poor in all cases, a more extensive study on the 
QUINAP-type system enabled the interception and characterization of all commonly accepted 
intermediates of the phosphine-catalyzed aza-BH reaction. 
Furthermore, the chiral aminoalcohol 160 was synthesized in a six-step sequence 
starting form trans-4-hydroxy-L-proline (Scheme 70). The overall yield of this successful and 
modular synthesis was 37%. Evaluation of this compound as a catalyst for the aza-BH 
reaction, however, displayed this vic-aminoalcohol as inactive. 
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Scheme 70. Synthesis of vic-aminoalcohol 160. 
 
 A complementary approach was chosen with the application of a solvent as the sole 
source of chirality for the aza-BH reaction. An anion-chiral IL with an acidic side group was 
specifically designed for this process. The PPh3-catalyzed aza-BH coupling of tosylaldimines 
with MVK yielded the corresponding reaction products in enantioselectivities up to 84% ee 
(er = 11.5; ΔΔG‡ = 6.05 kJ·mol-1) in IL 166 (Scheme 71).  
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Scheme 71. Aza-BH reaction in methyltrioctyl dimalatoborate (166) (X = CH3, Br, NO2; PR3 
= PPh3, P(o-tolyl)3, (C6F5)PPh2). 
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So far, this is the highest enantioselectivity obtained with a chiral solvent as the sole source of 
chirality for an asymmetric reaction. 
 
In future experiments, the racemization process should be investigated more intensively. 
Especially, a detailed study towards the rate law for this process would provide valuable 
additional information for processing the aza-BH reaction in an enantioselective way. 
Additionally, the mechanism of chirality transfer should be readdressed. To determine the 
exact influence of the activating group and fully clarify the mechanism, additional theoretical 
and experimental studies, e.g. on matched-mismatched effects of succesfull catalysts with S-
chiral sulfinimines, are required. 
 Regarding the chiral vic-aminoalcohols based on trans-4-hydroxy-L-proline, a 
variation of the protecting group on the Nitrogen atom seems a viable strategy for tuning the 
nucleophilicity of these compounds. It is expected that increasing the nucleophilicity of the 
aminogroup leads to an active catalyst for the aza-BH reaction. Furthermore, vic-
aminoalcohol 160 as well as its TBS-protected precursor 159 may serve as chiral backbone 
chiral for the formation of catalysts for other organocatalytic processes as well as ligands for 
homogeneous transition metal catalysis. 
 Concerning the reaction in anion-chiral ILs, a more extensive screening of substrates 
would provide valuable information on the flexibility of this catalytic system. Furthermore, 
mechanistic investigations on the structure and dynamics of these solvents and their 
interaction with dissolved substances are inevitable for the clarification of the mechanism of 
chirality transfer in these media. Useful experiments in this respect are: 
 
1. Dilution experiments with conventional, achiral ILs: How does the activity and 
enantioselectivity of the system depend on the fraction of chiral IL in the solvent 
mixture? 
2. Controlled addition of impurities: What are the influences of impurities like water on 
the system’s activity and enantioselectivity? 
3. NMR spectroscopic studies: Is there a signal shift upon dissolution of a compound in 
the IL and does this correlate to the coordination strength of the IL? 
 
In summary, a detailed insight into the mechanism of the aza-BH reaction under bifunctional 
activation was obtained. This provided useful information for the development of the first 
efficient enantioselective system in which the solvent is used as the sole source of chirality. 
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Based on these results, future synthetic and mechanistic work in this research area seems very 
promising.  
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5. Experimental 
   
5.1. General Methods, Solvents and Reagents 
 
5.1.1. Inert Gas Conditions 
 
All reactions involving air-sensitive chemicals were performed under Argon atmosphere 
using standard Schlenk techniques. Glassware was heated in vacuo and subsequently purged 
with Argon. The addition of reagents and solvents was carried out with polypropylene 
syringes equipped with V2A steel needles under an Argon stream. Sensitive chemicals like 
MVK were degassed and stored under Argon at −30°C. 
 
5.1.2. Solvents 
 
The following solvents were dried and purified by distillation under Argon according to 
standard procedures (Table 11).[150] For the purification of the corresponding deuterated 
solvents, identical procedures were applied.  
 
Table 11. Purification conditions for solvents. 
 
entry solvent conditions 
1 tetrahydrofurane heated under reflux over sodium benzophenone ketyl,  
followed by distillation under Argon 
2 diethylether heated under reflux over sodium benzophenone ketyl,  
followed by distillation under Argon 
3 toluene heated under reflux over sodium benzophenone ketyl,  
followed by distillation under Argon 
4 benzene heated under reflux over sodium benzophenone ketyl,  
followed by distillation under Argon 
5 chloroform heated under reflux over calcium hydride,  
followed by distillation under Argon 
6 dichloromethane heated under reflux over calcium hydride,  
followed by distillation under Argon 
7 pentane heated under reflux over calcium hydride, 
followed by distillation under Argon 
8 acetone heated under reflux over calcium chloride,  
followed by distillation under Argon 
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N,N-Dimethylformamide (DMF) and dimethylsulfoxide (DMSO) were purchased from 
Aldrich in following quality:  
 
(a) DMF: puriss, absolute, over MS 4Å (H2O ≤ 50 ppm)  under nitrogen 
(b) DMSO: water-free (H2O ≤ 50 ppm) under nitrogen 
 
Furthermore, all solvents for column chromatography, recrystallization and reaction workup 
were distilled prior to use. 
 
5.1.3. Reagents 
 
The commercially obtained reagents which were used in this Ph.D. project were obtained 
from various suppliers and in different qualities. Appendix 2 contains a detailed list with 
reagent, supplier and quality. 
(R)-2’-diphenylphosphanyl-[1,1’]binaphthalenyl-2-ol (88) and (R,S)-2-diphenylphos-
phanyl cyclohexane carboxylic acid methyl ester were provided by Dr. Giancarlo Franciò. 
(R)-QUINAP (127) and its derivatives 128 and 129 were donated by Dr. John M. Brown FRS. 
The diphenylphosphinocarboxylic acids 136, 137 and 138 were kindly allocated by Dr. 
Christian Steffens. The chiral ILs 170 and 171 were donated by Dipl.-Chem. Rolf Gausepohl. 
 
5.2. Determination of Physical Data 
 
5.2.1. NMR Spectroscopy 
 
1H-, 13C-, 31P-, 19F- and 11B NMR spectra were recorded on Bruker DPX 200, DPX 300, AV 
400, AV 500 and AV 600 spectrometers. The operating frequencies of these spectrometers for 
NMR measurements are listed in Table 12.  For 1H- and 13C NMR spectroscopy, the chemical 
shifts δ are given in ppm using the residual solvent signals as internal standard. For 31P- and 
19F-NMR spectroscopy the chemical shift values δ are given in ppm relative to 85% 
phosphoric acid and hexafluorobenzene as external standard, respectively. The multiplicity of 
the signals was assigned assuming spectra of first order. The coupling constant J is given in 
Hertz. For the description of the multiplicity of the signal following abbreviations are used: s 
  86
= singulet, d = doublet, t = triplet, q = quadruplet, m = multiplet, br = broad. The proton 
which belongs to the signal is underlined in the added structure section. Unless indicated 
otherwise, the spectra are recorded at room temperature. 
 
Table 12. Operating Frequencies of NMR spectrometers. 
 
entry spectrometer operating 
frequency / 
MHz 
    
  1H 13C 31P 19F 11B 
1 DPX 200 200.1 50.3 81.0 188.3 64.2 
2 DPX 300 300.1 75.5 121.5 282.4 96.3 
3 AV 400 400.1 100.6 162.0 376.5 128.4 
4 AV 500 500.1 125.8 202.5 470.6 160.5 
5 AV 600 600.1 150.9 242.9 564.7 192.5 
 
5.2.2. IR Spectroscopy  
 
IR spectra were recorded with a Perkin-Elmer spectrometer (PE 1720X, PE 1760 FT). The 
measurements were carried out on a film between two plates of KBr for liquids, in CHCl3 for 
oils and KBr pills for solids. The positions of the absorption signals are listed in cm−1. Only 
signals with a transmission T ≤ 80% are reported. The peak intensity is characterized using 
the following abbreviations: vs (very strong, 0% ≤ T ≤ 20%), s (strong, 20% < T ≤ 40%), m 
(medium, 40% < T ≤ 60%), w (weak, 60% < T ≤ 80%).   
 
5.2.3. Mass Spectroscopy 
 
Mass spectroscopic (MS) measurements were performed on a Finnigan SSQ 7000 (EI 70 eV, 
CI 100 eV) or Fisons Platform spectrometer (Electrospray mode). High-resolution MS 
measurements were carried out on a Finnigan MAT 95 or Micromass QTOF Micro 
spectrometer (Electrospray mode). 
 The mass of fragments (m/z) is given using a number without dimension with the 
relative peak intensity added in brackets. For high-resolution MS, the mass of the molecule 
ion is given. The error Δ is given in ppm (Equation 5). 
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calc
calcobs
m
mm −=Δ 610                                                                                    Equation 5 
 
Δ = error (in ppm) 
mobs = observed mass 
mcalc = calculated mass 
 
5.2.4. Gas Chromatography 
 
GC analysis was performed on a HP5890 (serie 2) using a Si 54 column of 25 m length. 
Following temperature program was applied: 50°C (1 min) – 8°C/min – 250°C (5 min).  
 
5.2.5. High Performance Liquid Chromatography 
 
HPLC analyses of the aza-BH products 106 (p-Br), 169 (p-CH3), 114 (p-NO2), 89 (H) and 
103 (m-F) were performed on Diacel Chiralcel OD-H, AD-H or Chiralpack IA column at 
20°C. 
 
106 (p-Br): 223 nm, heptane/isopropanol = 85/15, flow rate 0.5 ml/min, t(S) = 31.4 min, t(R) 
= 35.1 min (Diacel Chiralcel OD-H) 
169 (p-CH3): 223 nm, heptane/ethanol = 90/10, flow rate 0.5 ml/min, t(S) = 52.1 min, t(R) =   
60.7 min (Chiralpack IA) 
114 (p-NO2): 223 nm, heptane/ethanol = 80/20, flow rate 0.7 ml/min, t(S) = 39.6 min, t(R) = 
61.1 min (Chiralpack IA) 
89 (H): 223 nm, heptane/isopropanol = 85/15, flow rate 0.5 ml/min, t1 = 42.6 min, t2 = 49.0 
min (Chiralcel AD-H) 
103 (m-F): 223 nm, heptane/isopropanol = 85/15, flow rate 0.5 ml/min, t1 = 38.0 min, t2 = 
46.5 min (Chiralcel AD-H) 
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5.2.6. Thin Layer Chromatography 
 
For Thin Layer Chromatography (TLC), POLYGRAM SIL G/UV254 plates from Macherey 
and Nagel with a silica layer of 0.2 mm were used. Vizualization was realized through UV or 
permanganate treatment. 
 
5.3. Preparative Column Chromatography 
 
For preparative column chromatography, KIESELGEL 60 from Merck with a particle size in 
the range of 0.040 – 0.063 mm was used. The chromatographic purification was carried out 
according to the general procedure by Still and co-workers.[151] 
 
5.4. Syntheses 
 
5.4.1. Aromatic Tosylaldimines 
 
N S
O
O
N S
O
O
Br
N S
O
O
N S
O
O
O2N
N S
O
O
F
67 168 105
113102  
 
Synthesis of N-Benzylidene-4-methylbenzenesulfonamide (67) as prototypical procedure: 
 
According to Love and co-workers,[152] tosylamide (8.56 g, 50.0 mmol, 1.00 eq) was added to 
a mixture of benzaldehyde (5.07 ml, 50.0 mmol, 1.00 eq) and tetraethoxysilane (11.7 ml, 52.5 
mmol, 1.05 eq) under inert gas conditions. The resulting suspension was heated in a 
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distillation apparatus to 170°C and stirred overnight. Ethanol was continuously removed by 
distillation. The product was isolated by crystallization from a mixture of ethyl acetate and 
pentane. 
 
Yield: 9.72 g (37.5 mmol, 75%) 
 
1H NMR (300 MHz, CDCl3): δ = 9.05 (s, 1H, imine-H), 7.96-7.89 (m, 4H, Ar), 7.63 (m, 1H, 
Ar), 7.50 (dd {3JHH = 7.7 Hz, 3JHH = 7.3 Hz}, 2H, Ar), 7.37 (d {3JHH = 8.6 Hz}, 2H, Ar), 2.45 
(s, 3H, tos-CH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ = 170.2, 144.7, 135.1, 135.0, 132.4, 131.3, 129.8, 129.2, 
128.1, 21.7 ppm. 
 
TLC: Rf = 0.40 (pentane/ethyl acetate = 5/1) 
 
N-(4-Methylbenzylidene)-4-methylbenzenesulfonamide (168) 
 
Yield: 58% 
 
1H NMR (300 MHz, CDCl3): δ = 9.00 (s, 1H, imine-H), 7.90 (d {3JHH = 8.2 Hz}, 2H, Ar), 7.83 
(d {3JHH = 8.2 Hz}, 2H, Ar), 7.35 (d {3JHH = 8.2 Hz}, 2H, Ar), 7.30 (d {3JHH = 8.2 Hz}, 2H, 
Ar), 2.45 (s, 3H, CH3), 2.44 (s, 3H, CH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ = 170.0, 146.4, 144.5, 135.4, 131.4, 130.0, 129.9, 129.8, 
128.0, 22.0, 21.7 ppm. 
 
TLC: Rf = 0.37 (pentane/ethyl acetate = 5/1) 
 
N-(4-Bromobenzylidene)-4-methylbenzenesulfonamide (105) 
 
Yield: 65% 
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1H NMR (300 MHz, CDCl3): δ = 8.90 (s, 1H, imine-H), 7.80 (d {3JHH = 8.3 Hz}, 2H, Ar), 7.70 
(d {3JHH = 8.5 Hz}, 2H, Ar), 7.55 (d {3JHH = 8.5 Hz}, 2H, Ar), 7.27 (d {3JHH = 8.3 Hz}, 2H, 
Ar), 2.36 (s, 3H, tos-CH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ = 168.8, 144.8, 134.8, 132.6, 131.2, 130.3, 129.9, 128.2, 21.7 
ppm. 
 
TLC: Rf = 0.43 (pentane/ethyl acetate = 5/1) 
 
N-(3-Fluorobenzylidene)-4-methylbenzenesulfonamide (102) 
 
Yield: 79% 
 
1H NMR (300 MHz, CDCl3): δ = 9.03 (s, 1H, imine-H), 7.91 (d {3JHH = 8.4 Hz}, 2H, Ar), 7.83 
(d {3JHH = 8.4 Hz}, 1H, Ar), 7.71-7.65 (m, 2H, Ar), 7.49 (m, 1H, Ar), 7.38 (d {3JHH = 8.4 
Hz}, 2H, Ar), 2.46 (s, 3H, tos-CH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ = 168.8 (d {JCF =3.1 Hz}), 162.8 (d {JCF = 249.1}), 145.0, 
134.7, 134.5 (d {JCF = 7.6 Hz}), 130.9 (d {JCF = 8.0}), 129.9, 128.2, 127.9 (d{JCF = 3.1 Hz}), 
121.9 (d {JCF = 21.8 Hz}), 116.6 (d {JCF = 22.5 Hz}), 21.7 ppm. 
 
19F NMR (282.4 MHz, CDCl3): δ =  −112.6 ppm. 
 
TLC: Rf = 0.35 (pentane/ethyl acetate = 5/1) 
 
N-(4-Nitrobenzylidene)-4-methylbenzenesulfonamide (113) 
 
Yield: 86% 
 
1H NMR (300 MHz, CDCl3): δ = 9.04 (s, 1H, imine-H), 8.26 (d {3JHH = 8.7 Hz}, 2H, Ar), 8.04 
(d {3JHH = 8.7 Hz}, 2H, Ar), 7.84 (d {3JHH = 8.3 Hz}, 2H, Ar), 7.31 (d {3JHH = 8.3 Hz}, 2H, 
Ar), 2.39 (s, 3H, tos-CH3) ppm. 
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13C NMR (75.5 MHz, CDCl3): δ = 167.3, 145.4, 137.4, 134.1, 131.9, 130.0, 129.9, 128.4, 
124.2, 21.7 ppm. 
 
TLC: Rf = 0.26 (pentane/ethyl acetate = 5/1) 
 
5.4.2. Racemic Aza-Baylis-Hillman Products 
 
NH OS
O
O NH O
S
O
O
NH OS
O
O
Br
NH OS
O
O
O2N
NH OS
O
O
F
89 169 106
103 114  
 
Synthesis of 4-Methyl-N-(2-methylene-3-oxo-1-phenylbutyl)-4-methylbenzenesulfon-
amide (89) as prototypical procedure: 
 
N-Benzylidene-4-methylbenzenesulfonamide (67) (1.647 g, 5.00 mmol, 1.00 eq), DABCO 
(56.1 mg, 0.50 mmol, 0.10 eq) and phenol (47.1 mg, 0.50 mmol, 0.10 eq) were dissolved in 
dry THF (10 ml, 2 ml⋅mmol−1). Then, MVK (0.499 ml, 6.00 mmol, 1.20 eq) was added to this 
solution. The reaction was stirred at room temperature. Conversion of the starting material 67 
to the corresponding aza-BH product 89 was monitored via TLC (pentane/ethylacetate = 5/1). 
After complete conversion, all volatiles were removed in vacuo and the solid residue was 
purified via column chromatography (pentane/ethyl acetate = 4/1 – 2/1). 
 
1H NMR (300 MHz, CDCl3): δ = 7.57 (d {3JHH = 8.3 Hz}, 2H, Ar), 7.11 (m, 5H, Ar), 7.02 (m, 
2H, Ar), 6.02 (s, 1H, CHH), 6.01 (s, 1H, CHH), 5.73 (d {3JHH = 8.7 Hz}, 1H,CHNH), 5.21 (d 
{3JHH = 8.7 Hz}, 1H,CHNH), 2.33 (s, 3H, tos-CH3), 2.07 (s, 3H, C(O)CH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ =198.8, 146.5, 143.3, 138.8, 137.4, 129.5, 128.5, 128.2, 
127.6, 127.3, 126.4, 58.7, 26.3, 21.5 ppm. 
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TLC: Rf = 0.14 (pentane/ethyl acetate = 5/1) 
 
4-Methyl-N-(2-methylene-3-oxo-1-p-tolyl-butyl)-benzenesulfonamide (169) 
 
1H NMR (300 MHz, CDCl3): δ =  7.58 (d {3JHH = 8.3 Hz}, 2H, Ar), 7.15 (d {3JHH = 8.6 Hz}, 
2H, Ar), 6.92 (m, 4H, Ar), 6.03 (s, 1H, CHH), 6.02 (s, 1H, CHH), 5.48 (d {3JHH = 8.4 Hz}, 
1H, CHNH), 5.16 (d {3JHH = 8.4 Hz}, 1H, CHNH), 2.34 (s, 3H, tos-CH3), 2.19 (s, 3H, p-
CH3), 2.09 (s, 3H, C(O)CH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ = 198.9, 146.6, 143.3, 137.4, 135.9, 129.5, 129.2, 128.0, 
127.3, 126.3, 58.7, 26.4, 21.5, 21.0 ppm. 
 
TLC: Rf = 0.12 (pentane/ethyl acetate = 5/1) 
 
N-[1-(4-Bromophenyl)-2-methylene-3-oxobutyl]-4-methylbenzenesulfonamide (106) 
 
1H NMR (300 MHz, CDCl3): δ = 7.55 (d {3JHH = 8.0 Hz}, 2H, Ar), 7.22 (d {3JHH = 7.8 Hz}, 
2H, Ar), 7.16 (d {3JHH = 8.0 Hz}, 2H, Ar), 6.88 (d {3JHH = 7.8 Hz}, 2H, Ar), 6.00 (m, 3H, 
CHH and  CHNH), 5.16 (d {3JHH = 8.5 Hz}, 1H, CHNH), 2.33 (s, 3H, tos-CH3), 2.05 (s, 3H, 
C(O)CH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ = 198.8, 146.2, 143.6, 138.1, 137.5, 135.9, 131.3, 129.6, 
128.6, 128.3, 127.2, 121.5, 58.0, 26.3, 21.5 ppm. 
 
TLC: Rf = 0.12 (pentane/ethyl acetate = 5/1) 
 
N-[1-(3-Fluorophenyl)-2-methylene-3-oxobutyl]-4-methylbenzenesulfonamide (103) 
 
1H NMR (300 MHz, CDCl3): δ = 7.58 (d {3JHH = 8.3 Hz}, 2H, Ar), 7.16 (d {3JHH = 8.3 Hz}, 
2H, Ar), 7.10 (m, 1H, Ar), 6.80 (m, 3H, Ar), 6.02 (s, 1H, CHH), 6.01 (s, 1H, CHH), 5.76 (d 
{3JHH = 8.8 Hz}, 1H, CHNH), 5.19 (d {3JHH = 8.8 Hz}, 1H, CHNH), 2.35 (s, 3H, tos-CH3), 
2.09 (s, 3H, C(O)CH3) ppm. 
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13C NMR (75.5 MHz, CDCl3): δ = 198.8, 162.6 (d {JCF = 245 Hz}), 146.0, 143.6, 141.5 (d 
{JCF = 6.8 Hz}), 137.4, 130.0 (d{JCF = 8.4 Hz}), 129.6, 128.9, 127.3, 122.0 (d {JCF = 2.8 
Hz}), 114.2 (d {JCF = 21.2 Hz}), 113.7 (d {JCF = 22.8 Hz}), 58.6, 26.3, 21.5 ppm. 
 
19F NMR (282.4 MHz, CDCl3): δ =  −114.1 ppm. 
  
TLC: Rf = 0.14 (pentane/ethyl acetate = 5/1) 
 
4-Methyl-N-[2-methylene-1-(4-nitrophenyl)-3-oxobutyl]-benzenesulfonamide (114) 
 
1H NMR (300 MHz, CDCl3): δ = 8.09 (d {3JHH = 8.7 Hz}, 2H, Ar), 7.68 (d {3JHH = 8.3 Hz}, 
2H, Ar), 7.39 (d {3JHH = 8.7 Hz}, 2H, Ar), 7.28 (d {3JHH = 8.3 Hz}, 2H, Ar), 6.10 (m, 3H, 
CHNH and CHH), 5.35 (d {2JHH = 9.4 Hz}, 1H, CHNH), 2.45 (s, 3H, tos-CH3), 2.18 (s, 3H, 
C(O)CH3) ppm. 
 
13C NMR (300 MHz, CDCl3): δ = 198.7, 147.2, 146.3, 145.5, 143.9, 137.3, 129.7, 129.6, 
127.3, 127.2, 123.6, 58.7, 26.2, 21.5 ppm. 
 
TLC: Rf = 0.03 (pentane/ethyl acetate = 5/1) 
 
5.4.3. Enantiomerically Enriched Aza-Baylis-Hillman Products 
 
NH OS
O
O
NH OS
O
O
O2NBr
(S)-114(S)-106  
 
Synthesis of (S)-N-[1-(4-bromophenyl)-2-methylene-3-oxobutyl]-4-methylbenzene-
sulfonamide (106) as prototypical procedure: 
 
N-(4-Bromobenzylidene)-4-methylbenzenesulfonamide (105) (338.2 mg, 1.00 mmol, 1.00 eq) 
and (R)-2’-diphenylphosphanyl-[1,1’]binaphthalenyl-2-ol (88) (45.4 mg, 0.10 mmol, 0.10 eq) 
were dissolved in THF (8.0 ml, 8.0 ml⋅mmol−1) under inert gas conditions. After addition of 
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MVK (99.9 μl, 1.20 mmol, 1.20 eq), the reaction mixture was stirred at room temperature for 
24 h. Then, all volatiles were removed in vacuo and the residue was purified via column 
chromatography (pentane/ethyl acetate = 4/1 – 2/1). 
 
Yield: 60% 
 
Enantiomeric excess: 88% (S) 
 
NMR data: see rac-106 
 
(S)-4-Methyl-N-[2-methylene-1-(4-nitrophenyl)-3-oxobutyl]-benzenesulfonamide (114) 
 
Yield: 98% 
 
Enantiomeric excess: 74% (S)  
 
NMR data: see rac-114 
 
5.4.4. (R,S)-2-Diphenylphosphanyl cyclohexane carboxylic acid (140) 
 
COOH
PPh2
140  
 
(R,S)-2-diphenylphosphanyl cyclohexane carboxylic acid methyl ester (326.0 mg, 1.00 mmol, 
1.00 eq) was dissolved in ethanol (4 ml, 4 ml⋅mmol−1 ester) under Argon at room temperature. 
Then, a solution of KOH (98.2 mg, 1.75 mmol, 1.75 eq) in degassed water (3.5 ml, 2 
ml⋅mmol−1 KOH) was added dropwise and the resulting mixture was heated under reflux for 4 
h. After removal of all volatiles in vacuo, degassed water was added (4 ml, 4 ml⋅mmol−1 ester) 
and the aqueous phase was extracted with dichloromethane (3 x 8 ml, 3 x 2 ml⋅mmol−1 ester) 
under Argon. The organic phase was separated and dried over Na2SO4. All volatiles were 
removed in vacuo and (R,S)-2-diphenylphosphanyl cyclohexane carboxylic acid (140) was 
isolated as a colorless crystalline solid. 
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Yield: 309 mg (0.99 mmol, 99%) 
 
1H NMR (300 MHz, [D8]THF): δ = 7.58 (m, 4H, Ar), 7.42 (m, 6H, Ar), 2.85 (m, 1H, 
CHPPh2), 2.35 (m, 1H, CHCOOH), 2.10 (m, 1H, CHHCHCOOH), 1.85 (m, 1H, CHHCHP), 
1.75 (m, 1H, CHHCHCOOH), 1.50 (m, 1H, CHHCHHCHP), 1.42 (m, 1H, 
CHHCHHCHCOOH), 1.35 (m, 1H, CHHCHHCHP), 1.22 (m, 1H, CHHCHP), 1.10 (m, 1H, 
CHHCHHCHCOOH) ppm. 
 
13C NMR (75.5 MHz, [D8]THF): δ = 174.8 (d {JPC = 5.4 Hz}), 136.8 (d {JPC = 15.0 Hz}), 
135.8 (d {JPC = 18.0 Hz}), 134.2 (d {JPC = 21.1 Hz}), 132.0 (d {JPC = 17.5 Hz}), 128.3, 127.7 
(d {JPC = 5.6 Hz), 127.5 (d {JPC = 7.5 Hz}), 127.3, 44.2 (d {JPC = 19.9 Hz}), 34.6 (d {JPC = 
15.1}), 28.2 (d {JPC = 10.5 Hz}), 25.6 (d {JPC = 3.4 Hz}), 24.3, 24.1 (d {JPC = 0.9 Hz}) ppm. 
 
31P NMR (121.5 MHz, [D8]THF): δ = −6.11 ppm. 
 
5.4.5. (3-Oxobutyl)triphenylphosphonium malate (109) 
 
O
Ph3P
O
O
HO
O
OH
109  
 
Triphenylphosphine (15.7 mg, 0.060 mmol, 1.00 eq) and MVK (4.99 μl, 0.060 mmol, 1.00 eq) 
were dissolved in [D8]THF under Argon. After addition of L-(−)-malic acid (8.0 mg, 0.060 
mmol, 1.00 eq), the mixture was stirred at room temperature for 5 minutes and transferred 
into an NMR tube under Argon. The mixture was analyzed via NMR spectroscopy. 
 
Conversion: 95% 
 
1H NMR (300 MHz, [D8]THF): δ = 9.62 (br. s., 1H, COOH), 7.78 (m, 3H, Ar), 7.63 (m, 12H, 
Ar), 3.98 (dd {2JHH = 9.3 Hz, 2JHH = 4.9 Hz}, 1H, CHOH), 3.55 (dt {2JPH = 12.9 Hz , 3JHH = 
7.3 Hz}, 2H, PCH2CH2), 2.95 (dt {3JPH = 12.9, 3JHH = 7.3 Hz}, 2H, PCH2CH2), 2.57 (d {3JHH 
= 4.9 Hz} 1H, CHHCOOH), 2.55 (d {3JHH = 9.3 Hz}, 1H, CHHCOOH), 2.05 (s, 3H, 
C(O)CH3) ppm. 
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13C NMR (75.5 MHz, [D8]THF): δ = 203.9 (d {JPC = 10.8 Hz}), 178.1, 173.9, 133.4 (d {JPC = 
10.0 Hz}), 130.7 (d {JPC = 12.7 Hz}), 118.3, 117.2, 66.2, 41.3, 35.4 (d {JPC = 3.1 Hz}), 29.6, 
21.6 (d {JPC = 56.4}) ppm. 
 
31P NMR (121.5 MHz, [D8]THF): δ = 25.3 ppm. 
 
5.4.6. [1-(3-Carboxylato-isoquinolin-1-yl)-naphthalen-2-yl]-(3-oxobutyl)-diphenyl-
phosphonium (131) 
 
N
P
O
Ph Ph
O
O
131  
 
MVK (4.16 μl, 0.050 mmol, 1.00 eq) was added to a solution of rac-1-(2-
diphenylphosphanylnaphthalen-1-yl)-isoquinoline-3-carboxylic acid (128) (24.0 mg, 0.050 
mmol, 1.00 eq) in CDCl3 (0.7 ml, 14 ml⋅mmol−1). The mixture was stirred at room 
temperature for 5 min. After filtration, the resulting solution was analyzed via NMR 
spectroscopy and High-Resolution MS. 
 
Conversion: 64% 
 
1H NMR (300 MHz, CDCl3): δ = 8.05 (dd {3JHH = 8.8 Hz, 3JHP = 2.7 Hz}, 1H, Ar), 7.94 (m, 
2H, Ar), 7.84 (m, 2H, Ar), 7.72 (m, 2H, Ar), 7.60 (m, 4H, Ar), 7.49 (m, 4H, Ar), 7.20 (m, 6H, 
Ar), 4.76 (m, 1H, PCHHCHH), 3.94 (m, 1H, PCHHCHH), 3.30 (m, 1H, PCHHCHH), 3.09 
(m, 1H, PCHHCHH), 2.02 (s, 3H, C(O)CH3) ppm  
 
13C NMR (75.5 MHz, CDCl3): δ = 37.4 (d {JPC = 4.0}), 29.7, 16.8 (d {JPC = 55.7 Hz}) 
ppm.[153] 
 
31P NMR (162.0 MHz, CDCl3): δ = 26.8 ppm. 
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HR-MS (ESI+): (m/z)obs = 554.1866 (Δ = 2.4 ppm) 
 
5.4.7. (R)-(1-Isoquinolin-1-yl-naphthalen-2-yl)-(3-oxobutyl)-diphenylphosphonium diphenyl-
acetate (172) 
N
P
Ph2
O
O
O
172  
 
MVK (4.2 μl, 0.050 mmol, 1.00 eq) was added to a solution of (R)-QUINAP (127) (22.0 mg, 
0.050 mmol, 1.00 eq) and diphenyl acetic acid (10.7 mg, 0.050 mmol, 1.00 eq) in CDCl3 (0.5 
ml) under Argon. The reaction mixture was stirred at room temperature for 1 h. After 
filtration of the resulting suspension, the solution was analyzed via NMR spectroscopy.[154] 
 
Conversion: 15% 
 
1H NMR (400 MHz, CDCl3): δ = 5.06 (s, 1H, Ph2CH), 3.36 (m, 2H, PCH2CH2), 3.22 (m, 1H, 
PCH2CHH), 2.64 (m, 1H, PCH2CHH), 2.29 (s, 3H, C(O)CH3) ppm. 
 
31P NMR (162.0 MHz, CDCl3): δ = 26.43 ppm. 
 
5.4.8. (R,R)- and (S,R)-{1-[3-(3-Hydroxy-2-phenylpropylcarbamoyl)-isoquinolin-1-yl]-
naphthalen-2-yl}-(3-oxobutyl)-diphenylphosphonium diphenylacetate (173) 
 
N
P
Ph2
O
H
N OH
Ph
O
O
O
173  
 
A 1:1-mixture of (R,R)- and (S,R)-1-(2-diphenylphosphanylnaphthalen-1-yl)-isoquinoline-3-
carboxylic acid (3-hydroxy-2-phenylpropyl)-amide (129) (60.3 mg, 0.100 mmol,  1.00 eq) 
and MVK (8.32 μl, 0.100 mmol, 1.00 eq) were dissolved in [D6]benzene (1.5 ml) under 
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Argon. After addition of diphenyl acetic acid (21.3 mg, 0.100 mmol, 1.00 eq), the mixture 
was stirred at room temperature for 5 min, filtered and transferred into a NMR tube under 
inert gas. The resulting solution was analyzed via NMR spectroscopy.[154] 
 
Conversion: 32% 
 
1H NMR (400 MHz, [D6]benzene): δ = 3.48 (m, 2H, PCH2CH2), 3.00 (m, 2H, PCH2CH2), 
2.02 (s, 3H, C(O)CH3) ppm. 
 
31P NMR (162.0 MHz, [D6]benzene): δ = 26.0 ppm. 
 
5.4.9. [1-(3-Carboxy-isoquinolin-1-yl)-naphthalen-2-yl]-{3-oxo-2-[phenyl-(toluene-4-
sulfonylamino)-methyl]-butyl}-diphenyl-phosphonium diphenylacetate (132) 
 
N
COOH
P
O
Ph Ph
Ph
N
H
Tos O
O
132  
 
rac-1-(2-Diphenylphosphanylnaphthalen-1-yl)-isoquinoline-3-carboxylic acid (128) (30.2 mg, 
0.050 mmol, 1.00 eq), rac-4-Methyl-N-(2-methylene-3-oxo-1-phenylbutyl)-4-methylbenzene-
sulfonamide (89) (16.5 mg, 0.050 mmol, 1.00 eq) and  diphenylacetic acid (10.7 mg, 0.050 
mmol, 1.00 eq) were dissolved in 0.7 ml [D8]toluene. The mixture was stirred at room 
temperature for 8 h, filtered and subsequently analyzed via NMR spectroscopy and High-
Resolution MS.[153] 
 
Conversion: 13% 
 
1H NMR (400 MHz, [D8]toluene): δ = 5.93 (m, 1H, PCHHCH), 4.90 (m, 1H, PCHHCHCH), 
4.68 (m, 1H, PCHHCH), 4.17 (m, 1H, PCHHCH) ppm. 
 
31P NMR (162.0 MHz, [D8]toluene): δ = 22.2 ppm. 
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HR-MS (ESI+): (m/z)obs = 813.2544 (Δ = 0.3 ppm) 
 
5.4.10. Methyltrioctyl ammonium dimalatoborate (166) 
 
[MtOA]
O O
O
O
O
O
O OB
O
O
HH
166  
 
The synthesis was performed according to the procedure developed by Gausepohl.[146] 
 
Sodium dimalatoborate (165): L-(−)-malic acid (10.73 g, 80.0 mmol, 2.00 eq) was dissolved 
in water (10 ml, 0.125 ml⋅mmol−1 malic acid) and treated with boric acid (2.47 g, 40.0 mmol, 
1.00 eq). Then, a solution of sodium hydroxide (1.60 g, 40.0 mmol, 1.00 eq) in water (30 ml, 
0.75 ml⋅mmol−1 NaOH) was added. The reaction mixture was stirred in an open flask at 
100°C. After evaporation of the water (ca. 4 h), sodium dimalatoborate (165) was isolated as a 
colorless powder.  
 
Yield: 11.92 g (40.0 mmol, > 99%) 
 
1H NMR (600 MHz, [D6]DMSO): δ = 12.24 (s, 2H, COOH), 4.32 and 4.31 (dd {3JHH,cis = 3.3 
Hz, 3JHH,trans = 8.8 Hz}, 2H, CHOB), 2.53 and 2.49 (dd {3JHH,cis = 3.3 Hz, 2JHH = 15.8 Hz}, 
2H, CHH), 2.27 and 2.25 (dd {3JHH,trans = 8.8 Hz, 2JHH = 15.8 Hz}, 2H, CHH) ppm. 
 
13C NMR (150 MHz, [D6]DMSO): δ = 178.3 and 178.2, 172.6, 72.7 and 72.4, 39.6 and 39.5 
ppm. 
 
11B NMR (192.5 MHz, D2O): δ = 9.85 ppm. 
 
Methyltrioctyl ammonium dimalatoborate (166): Methyltrioctyl ammonium chloride 
(Aliquat 336®, 3.54 g, 8.75 mmol, 1.00 eq) was dissolved in acetone (20 ml, 2.3 ml⋅mmol−1) 
and treated with a solution of the sodium borate salt 165 (2.61 g, 8.75 mmol, 1.00 eq) in 
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acetone (20 ml, 2.3 ml⋅mmol−1). The reaction mixture was stirred at room temperature 
overnight. During this period sodium chloride precipitated as a colorless solid. The reaction 
mixture was filtered and the solvent was removed in vacuo to yield the IL 166 as a highly 
viscous, hygroscopic colorless liquid. 
 
Conversion: 72 ± 2% (determined from 1H NMR) 
 
1H NMR (600 MHz, [D6]DMSO): δ = 12.24 (s, 2H, COOH), 4.32 and 4.31 (dd {3JHH,cis = 3.3 
Hz, 3JHH,trans = 8.8 Hz}, 2H, CHOB), 3.22 (tt {3JHH = 8.2, 4JHH = 4.6 Hz}, 6H, C1-H2), 2.96 (s, 
3H, C9-H3), 2.54 and 2.50 (dd {3JHH,cis = 3.3 Hz, 2JHH = 15.8 Hz}, 2H, CHH), 2.28 and 2.26 
(dd {3JHH,trans = 8.8 Hz, 2JHH = 15.8 Hz}, 2H, CHH), 1.62 (m, 6H, C6-H2), 1.26 (m, 30H, [C2-
C5+C7]-H2) , 0.87 (tt {3JHH = 6.7 Hz, 4JHH = 2.2 Hz}, 9H, C8-H3) ppm. [155] 
 
13C NMR (150 MHz, [D6]DMSO): δ = 178.3 and 178.2, 172.6, 72.7 and 72.4, 60.4, 47.9, 39.6 
and 39.5, 31.1, 28.7, 28.7, 25.7, 22.0, 21.3, 13.9 ppm. 
 
11B NMR (192.5 MHz, [D6]DMSO): δ = 9.85 ppm. 
 
5.4.11. trans-4-Hydroxy-(S)-proline methylester hydrochloride (155) 
 
N
H2 O
O
HO
Cl−
155  
 
Thionylchloride (48.33 ml, 662.6 mmol, 3.13 eq) was carefully dissolved in methanol (250 
ml) at 0°C. Then, trans-4-hydroxy-L-proline (24.33 g, 211.3 mmol, 1.00 eq) was added to this 
solution in small portions. The resulting mixture was stirred at 0°C for 0.5 h. After warming 
to room temperature, the mixture was stirred for additional 24 h and subsequently 
concentrated in vacuo. The residue was taken up in methanol and diethyl ether was added 
until the product precipitated as a white solid. The solid was collected on a filter and washed 
with small portions of ether. The mother liquor was concentrated and a second crystallization 
furnished the product in quantitative yield. 
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Yield: 38.00 g (209.2 mmol, 99%) 
 
1H NMR (600 MHz, [D6]DMSO): δ = 9.95 (br. s, 2H, NH2), 5.67 (br. s, 1H, OH), 4.42 (m, 2H, 
CHOH and CHC(O)OCH3), 3.73 (s, 3H, C(O)OCH3), 3.35 (dd {2JHH = 12.1 Hz, 3JHH = 3.6 
Hz}, 1H, NH2CHHCH(OH)), 3.03 (br. d {2JHH = 12.1 Hz}, 1H, NH2CHHCH(OH)), 2.18 (m, 
1H, CH(OH)CHHCHC(O)OCH3), 2.07 (m, 1H, CH(OH)CHHCHC(O)OCH3) ppm. 
 
13C NMR (150 MHz, [D6]DMSO): δ = 169.5, 69.8, 58.4, 53.7, 53.0, 37.2 ppm. 
 
5.4.12. (2S,4R)-4-Hydroxy-1-benzoylproline methylester (156) 
 
N
O
O
HO
O
156  
 
Triethylamine (29.0 ml, 206.5 mmol, 2.50 eq) was added to a solution of trans-4-hydroxy-(S)-
proline methylester hydrochloride (155) (15.00 g, 82.6 mmol, 1.00 eq) in dichloromethane 
(90 ml, 6 ml⋅g−1 ester). The resulting mixture was stirred for 1.5 h at room temperature. After 
addition of DMAP (0.463 g, 4.1 mmol, 5 mol-%), benzoylchloride (9.52 ml, 82.6 mmol, 1.00 
eq) was added dropwise. The reaction mixture was stirred for 12 h at room temperature. The 
resulting suspension was washed with water (30 ml), hydrochloric acid (5%, 20 ml), 0.5 M 
NaOH (20 ml) and again water (30 ml). The organic phase was dried over Na2SO4 and 
concentrated in vacuo. The resulting residue was taken up in a small amount of 
dichloromethane. From this solution, the product was isolated as a white solid through 
precipitation with pentane.  
 
Yield: 16.48 g (66.1 mmol, 80%) 
 
1H NMR (300 MHz, CDCl3): δ = 7.55 (m, 2H, o-H), 7.40 (m, 3H, m-H and p-H), 4.82 (m, 1H, 
CHCO(O)CH3), 4.39 (m, 1H, CH(OH)), 3.75 (s, 3H, C(O)CH3), 3.50 (m, 2H, 
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NCHHCH(OH)), 3.27 (s, 1H, CH(OH)), 2.35 (m, 1H, CH(OH)CHHCHC(O)OCH3), 2.10 (m, 
1H, CH(OH)CHHCHC(O)OCH3) ppm. 
 
13C NMR (75.5 MHz, CDCl3): δ = 172.9, 170.3, 135.5, 130.4, 128.3, 127.5, 70.2, 58.0, 52.4, 
37.7 ppm. 
 
5.4.13. (2S,4R)-4-{[1-(tert-Butyl)-1,1’-dimethylsilyl]-oxy}-1-benzoylproline methylester (157) 
 
N
O
O
O
O
Si
157  
 
(2S,4R)-4-Hydroxy-1-benzoylproline methylester (156) (10.00 g, 40.12 mmol, 1.00 eq)  and 
imidazole (6.83 g, 100.3 mmol, 2.50 eq) were dissolved in DMF (50 ml, 5 ml⋅g−1 alcohol) and 
stirred at room temperature for 3 h. Then, a solution of tert-butyl-dimethylsilyl chloride in 
toluene (50 wt-%, 17.5 ml, 50.15 mmol, 1.25 eq) was added dropwise. The resulting mixture 
was stirred for 40 h at room temperature. After concentration in vacuo, the residue was 
dissolved in ether (60 ml) and washed with water (30 ml), diluted acetic acid (1M, 30 ml), 
saturated NaHCO3 solution (30 ml) and again water (2 x 30 ml). After that, the organic phase 
was dried over Na2SO4 and the solvent was removed in vacuo. The obtained colorless residue 
was used in the next step without further purification.  
 
Yield: 14.37 g (39.53 mmol, 99%) 
 
1H NMR (300 MHz, CDCl3): δ = 7.52 (m, 2H, Ar), 7.36 (m, 3H, Ar), 4.78 (t {3JHH = 8.2 Hz}, 
1H, CHC(O)OCH3), 4.40 (m, 1H, CHOSi), 3.76 (s, 3H, C(O)OCH3), 3.72 (m, 1H, 
NCHHCHOSi), 3.37 (m, 1H, NCHHCHOSi), 2.25 (m, 1H, SiOCHCHHCHC(O)OCH3), 2.05 
(m, 1H, SiOCHCHHCHC(O)OCH3), 0.79 (s, 9H, SiC(CH3)3), 0.00 (s, 3H, SiCH3), −0.08 (s, 
3H, SiCH3) ppm. 
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13C NMR (75.5 MHz, CDCl3): δ = 172.9, 170.2, 135.9, 130.3, 128.3, 127.4, 70.7, 58.1, 57.9, 
52.3, 38.4, 25.6, 17.8, −4.8, −5.0 ppm. 
 
5.4.14. (2S,4R)-4-{[1-(tert-Butyl)-1,1’-dimethylsilyl]-oxy}-1-benzyl-2-hydroxymethyl-
pyrrolidine (158) 
 
N
OH
OSi
158  
 
A suspension of LAH (3.445 g, 90.77 mmol, 3.30 eq) in THF (55 ml, 16 5 ml⋅g−1 LAH) was 
heated under reflux for 15 min. Then, a solution of (2S,4R)-4-{[1-(tert-butyl)-1,1’-
dimethylsilyl]-oxy}-1-benzoylproline methylester (157) (10.00 g, 27.51 mmol, 1.00 eq) in 
THF (15 ml, 1.5 ml⋅g−1 ester) was added at a rate keeping the mixture under gentle reflux. 
After complete addition, the mixture was heated under reflux for 1 h, cooled to room 
temperature and carefully hydrolyzed with 20%-KOH solution (15 ml, 1.5 ml⋅g−1 157). The 
solid was filtered off and extracted with ether under reflux for 1 h. The combined organic 
phase was concentrated and ether (50 ml, 5 ml⋅g−1 ester) was added. After drying over 
Na2SO4 and evaporation of the volatiles under reduced pressure, the obtained colorless oil 
was used in the next step without further purification. 
 
Yield: 8.75 g (27.41 mmol, 99%) 
 
1H NMR (300 MHz, CDCl3): δ = 7.28 (m, 5H, Ar), 4.25 (m, 1H, CHOSi), 3.95 (d {2JHH = 12.9 
Hz}, 1H, NCHHPh), 3.63 (dd {2JHH = 11.1 Hz, 3JHH = 3.4 Hz}, 1H, CHH(OH)), 3.45 (d {2JHH 
= 12.9 Hz}, 1H, NCHHPh), 3.36 (dd {2JHH = 11.1 Hz, 3JHH = 1.5 Hz}, 1H, CHHOH), 3.11 
(dd {2JHH = 9.8 Hz, 3JHH = 5.5 Hz}, 1H, NCHHCHOSi), 3.05 (m, 1H, NCHCH2), 2.34 (dd 
{2JHH = 9.8 Hz, 3JHH = 5.7 Hz}, 1H, NCHHCHOSi), 2.05 (m, 1H, NCHCHH), 1.82 (m, 1H, 
NCHCHH), 0.86 (s, 9H, SiC(CH3)3), 0.02 (s, 3H, SiCH3), 0.00 (s, 3H, SiCH3) ppm. 
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13C NMR (75.5 MHz, CDCl3): δ = 139.1, 128.7, 128.4, 127.1, 70.7, 68.0, 63.4, 62.3, 61.0, 
58.7, 37.9, 25.8, 18.0, −4.7, −4.8 ppm. 
 
5.4.15. (3R,5R)-1-Benzyl-3-(tert-butyl-dimethylsilanyloxy)-5-chloro-piperidine (159)   
 
N
ClOSi
159  
 
Methanesulfonylchloride (0.904 ml, 11.68 mmol, 1.10 eq) and triethylamine (5.93 ml, 42.48 
mmol, 4.00 eq) were added dropwise to a solution of (2S,4R)-4-{[1-(tert-butyl)-1,1’-
dimethylsilyl]-oxy}-1-benzyl-2-hydroxymethylpyrrolidine (158) (3.415 g, 10.62 mmol, 1.00 
eq) in THF (87 ml, 8.2 ml⋅mmol−1 alcohol) at 0°C. The mixture was heated under reflux for 
12 h. After cooling to room temperature, the reaction mixture was poured into 2.5 M NaOH 
solution (30 ml). After extraction with dichloromethane, the combined organic phase was 
dried over Na2SO4 and concentrated in vacuo. The resulting dark brown oil was purified via 
column chromatography with pentane/ethyl acetate = 3/1. 
 
Yield: 2.058 g (6.05 mmol, 57%) 
 
1H NMR (300 MHz, CDCl3): δ = 7.28 (m, 5H, Ar), 4.34 (m, 1H, CHOSi), 4.09 (m, 1H, 
CHCl), 3.68 (d {2JHH = 13.7 Hz}, 1H, NCHHPh), 3.50 (d {2JHH = 13.7 Hz}, 1H, NCHHPh), 
2.68 (dd {2JHH = 11.7 Hz, 3JHH = 2.7 Hz}, 1H, NCHHCHOSi), 2.55 (m, 2H, NCHHCHOSi 
and NCHHCHCl), 2.33 (dd {2JHH = 11.3 Hz, 3JHH = 6.1 Hz}, 1H, NCHHCHCl),  1.92 (m, 2H, 
SiOCHCHHCHCl), 0.86 (s, 9H, SiC(CH3)3), 0.02 (s, 3H, SiCH3), 0.00 (s, 3H, SiCH3) ppm. 
  
13C NMR (75.5 MHz, CDCl3): δ = 137.9, 128.8, 128.2, 127.0, 65.9, 62.0, 59.7, 59.6, 54.8, 
42.3, 25.8, 18.1, −4.7, −4.8 ppm. 
 
GC: t = 12.96 min 
 
MS (CI): m/z (%) = 340 (M+1, 100), 304 (49), 282 (17). 
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MS (EI): m/z (%) = 339 (M, 14), 304 (77), 296 (17), 290 (12), 282 (95), 134 (17), 91 (100), 
73 (12).  
 
HR-MS: (m/z)obs = 339.1785 (Δ = 0.2 ppm) 
 
IR (kap): ν = 2943 (vs), 2794 (w), 2352 (m), 1645 (m), 1461 (m), 1369 (w), 1258 (s), 1096 
(vs), 1038 (vs), 836 (vs), 782 (m) cm−1. 
 
5.4.16. (3R,5R)-1-Benzyl-5-chloro-piperidin-3-ol (160) 
 
N
ClHO
160  
 
(3R,5R)-1-benzyl-3-(tert-butyl-dimethylsilanyloxy)-5-chloro-piperidine (159) (339.9 mg, 1.00 
mmol, 1.00 eq) was dissolved in THF (15 ml, 15 ml⋅mmol−1 159) at room temperature. Then, 
a solution of tetra-n-butylammonium fluoride in dichloromethane (1 M, 2.00 ml, 2.00 mmol, 
2.00 eq) was added dropwise. After stirring at room temperature overnight, the reaction 
solution was poured into a biphasic mixture of aqueous NH4Cl and ether. The organic phase 
was separated and the resulting aqueous phase was extracted with ether. Then, the combined 
organic phases were washed with water and dried over Na2SO4. After removal of the solvent 
in vacuo, the remaining residue was purified via column chromatography with pentane/ethyl 
acetate = 1/1. 
 
Yield: 183.1 mg (0.811 mmol, 81%) 
 
1H NMR (300 MHz, CDCl3): δ = 7.33 (m, 5H, Ar), 4.25 (m, 1H, CHCl), 4.02 (m, 1H, OH), 
3.62 (s, 2H, NCH2Ph), 3.13 (m, 1H, CHOH), 2.81 (m, 1H, HOCHCHHCHCl), 2.30 (m, 4H, 
NCH2CHOH and NCH2CHCl), 1.72 (m, 1H, HOCHCHHCHCl) ppm. 
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13C NMR (75.5 MHz, CDCl3): δ = 137.2, 129.0, 128.5, 127.5, 66.0, 62.1, 60.9, 58.6, 52.5, 41.6 
ppm. 
 
MS (CI): m/z (%) = 226 (M+1, 100), 190 (16). 
 
MS (EI): m/z (%) = 225 (M, 66), 190 (13), 148 (16), 136 (15), 134 (58), 120 (10), 91 (100). 
 
HR-MS: (m/z)obs = 225.0921 (Δ = 0.4 ppm) 
 
IR (KBr): ν = 3177 (vs), 2932 (vs), 2840 (w), 2779 (vs), 2365 (s), 2342 (m), 1443 (s), 1353 
(w), 1293 (vs), 1142 (m), 1075 (m), 1000 (s), 880 (w), 794 (m), 746 (s), 687 (vs), 600 (w), 
482 (s) cm−1. 
 
5.5. Catalysis 
 
5.5.1. Screening of Lewis Base-Brønsted Acid Catalysts in the Aza-Baylis-Hillman Reaction 
 
As prototypical example, the screening of (R,S)-2-diphenylphosphanyl-
cyclohexanecarboxylic acid (140) in the coupling of N-(4-Bromobenzylidene)-4-
methylbenzenesulfonamide (105) with MVK (37) is described: 
 
Br
N Tos O
+
Br
NH OTos
COOH
PPh2
r.t., THF, 24 h
105 37
140
106  
 
N-(4-Bromobenzylidene)-4-methylbenzenesulfonamide (105) (51.0 mg, 0.125 mmol, 1.00 eq) 
and (R,S)-2-diphenylphosphanyl-cyclohexanecarboxylic acid (140) (3.90 mg, 0.0125 mmol, 
0.10 eq) were dissolved in THF under inert gas conditions. After addition of MVK (37) (12.5 
μl, 0.150 mmol, 1.20 eq), the reaction solution was stirred at room temperature for 24 h. Then, 
all volatiles were removed in vacuo. The composition of the resulting residue was analyzed 
via 1H NMR spectroscopy (conversion) and HPLC (enantiomeric excess). 
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Conversion: 86% 
 
Enantiomeric excess: rac 
 
5.5.2. Kinetic Experiments 
 
For all kinetic experiments, stock solutions were prepared to minimize the weighing error. 
They were stored under Argon at −10°C. 
 
a) Without Brønsted acid 
 
F
N Tos
O
+
PPh3, C6F6
THF, r.t.
F
NH OTos
102 37 103
53 104
 
 
Prototypical example: 
 
N-(3-Fluorobenzylidene)-4-methylbenzenesulfonamide (102) (16.60 mg, 59.9 μmol, 1.00 eq), 
PPh3 (53) (7.88 mg, 30.1 μmol, 0.50 eq) and C6F6 (104) (2.71 mg, 14.6 μmol, 0.24 eq) were 
dissolved in THF (0.60 ml) at room temperature. The reaction was performed in a sealed 
NMR tube under Argon. After addition of MVK (37) (7.18 μl, 86.3 μmol, 1.44 eq), 
conversion was monitored via 19F NMR spectroscopy for approximately 10 h. 
 
Starting concentrations:  
 
Partial order imine 102: c(53) = 0.0501 mol⋅l−1, c(37) = 0.1438 mol⋅l−1, c(104) = 0.0243 
mol⋅l−1, c(102) = 0.0998-0.2530 mol⋅l−1. 
 
Partial order MVK (37): c(53) = 0.0500 mol⋅l−1, c(102) = 0.1506 mol⋅l−1, c(104) = 0.0214 
mol⋅l−1, c(37) = 0.1712 – 0.3163 mol⋅l−1. 
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Partial order PPh3 (53): c(37) = 0.1531 mol⋅l−1, c(102) = 0.1514 mol⋅l−1, c(104) = 0.0285 
mol⋅l−1, c(53) = 0.0724 – 0.1595 mol⋅l−1. 
 
b) With Brønsted acid = phenol 
 
F
N Tos
O
+
PPh3, phenol, C6F6
THF, r.t.
F
NH OTos
102 37 103
53 111 104
 
 
Prototypical example: 
 
N-(3-Fluorobenzylidene)-4-methylbenzenesulfonamide (102) (16.01 mg, 57.7 μmol, 1.00 eq), 
PPh3 (53) (4.63 mg, 17.6 μmol, 0.31 eq), C6F6 (104) (3.81 mg, 20.5 μmol, 0.36 eq) and phenol 
(111) (8.94 mg, 95.0 μmol, 1.65 eq) were dissolved in THF (0.60 ml) at room temperature. 
The reaction was performed in a sealed NMR tube under Argon. After addition of MVK (37) 
(7.50 μl, 90.1 μmol, 1.56 eq), conversion was monitored on-line via 19F NMR spectroscopy 
for approximately 10 h. 
 
Starting concentrations: 
 
Partial order imine 102: c(53) = 0.0294 mol⋅l−1, c(37) = 0.1502 mol⋅l−1, c(111) = 0.1584 
mol⋅l−1, c(104) = 0.0341 mol⋅l−1, c(102) = 0.0962 – 0.1479 mol⋅l−1. 
 
Partial order MVK (37): c(53) = 0.0153 mol⋅l−1, c(111) = 0.1622 mol⋅l−1, c(104) = 0.0234 
mol⋅l−1, c(102) = 0.1532 mol⋅l−1, c(37) = 0.1474 – 0.2211 mol⋅l−1. 
 
Partial order phenol (111):  c(102) = 0.1264 mol⋅l−1, c(37) = 0.1527 mol⋅l−1, c(104) = 0.0350 
mol⋅l−1, c(53) = 0.0154 mol⋅l−1, c(111) = 0.087 – 0.166 mol⋅l−1. 
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5.5.3. Screening of Brønsted Acids for Kinetics 
 
For all kinetic experiments, stock solutions were prepared to minimize the weighing error. 
They were stored under Argon at −10°C. 
 
As prototypical example, the evaluation of benzoic acid as co-catalyst in the PPh3-
catalyzed coupling of N-(4-bromobenzylidene)-4-methylbenzenesulfonamide (105) with 
methyl vinyl ketone (37) in [D8]THF is described: 
 
N Tos
O
+
PPh3, benzoic acid
[D8] THF, r.t.
NH OTos
Br Br
105 10637
53
 
 
Benzoic acid (12.6 mg, 0.103 mmol, 1.375 eq) was added to a mixture of N-(4-
bromobenzylidene)-4-methylbenzenesulfonamide (105) (25.4 mg, 0.075 mmol, 1.00 eq) and 
PPh3 (53) (2.0 mg, 0.0075 mmol, 0.10 eq) in deuterated THF (0.60 ml) at room temperature. 
The reaction was performed in a sealed NMR tube under Argon. After addition of MVK (37) 
(7.5 μl, 0.090 mmol, 1.20 eq), conversion was monitored online via 1H NMR spectroscopy for 
700 min.   
 
The following compounds were also tested as additives: N-[1-(4-bromophenyl)-2-methylene-
3-oxobutyl]-4-methylbenzenesulfonamide (42.1 mg), methanol (3.3 mg), phenol (9.7 mg), N-
methyltosylamide (19.1 mg), bis-3,5-(trifluormethyl)phenol (23.7 mg), water (1.9 mg), malic 
acid (13.8 mg). 
 
5.5.4. Catalysis in Chiral Ionic Liquids 
 
As prototypical example, the PPh3-catalyzed coupling of N-(4-bromobenzylidene)-4-
methylbenzenesulfonamide (105) with MVK (37) in methyltrioctyl ammonium 
dimalatoborate (166) is described: 
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Br
N Tos O
+
Br
NH OTos
166, r.t., 24 h
PPh3
53
105 10637  
 
N-(4-Bromobenzylidene)-4-methylbenzenesulfonamide (105) (42.3 mg, 0.125 mmol, 1.00 eq) 
and catalyst 3 (3.3 mg, 12.5 μmol, 0.10 eq) were dissolved in methyltrioctyl ammonium 
dimalatoborate (166) (1.0 ml, 6.7 ml⋅mmol−1 imine). After addition of MVK (37) (12.5 μl, 
0.150 mmol, 1.20 eq), the reaction was stirred at room temperature for 24 h. After removing 
excess MVK (37) in vacuo, a small sample of the reaction mixture was dissolved in 
[D6]DMSO to determine the conversion by 1H NMR spectroscopy. The main part of the 
reaction mixture was dissolved in a 1:1 mixture of water and methanol (5 ml). Further 
methanol was added to obtain a clear solution of the reaction mixture. After (partly) 
exchanging the cation on an ion-exchange resin (contact time app. 5 min), all volatiles were 
removed in vacuo.[156]The resulting solid was extracted with heptane/iPrOH (85:15, 1 ml) and 
the solution was directly analyzed by chiral HPLC to determine the ee of the product. 
 
Conversion: 34 – 39% 
 
Enantiomeric excess: 71 – 84% ee 
 
5.5.5. Screening of Chiral Brønsted Acidic Additives 
 
As prototypical example, the PPh3-catalyzed coupling of N-(4-bromobenzylidene)-4-
methylbenzenesulfonamide (105) with MVK (37) using L-(−)-malic acid (162) as additive 
is presented: 
 
Br
N Tos O
+
Br
NH OTos
THF, r.t., 24 h
PPh3, L-(−)-malic acid
105 37 106
53 162
 
 
N-(4-Bromobenzylidene)-4-methylbenzenesulfonamide (105) (42.3 mg, 0.125 mmol, 1.00 
eq), triphenylphosphine (53) (3.3 mg, 0.0125 mmol, 0.10 eq) and L-(−)-malic acid (162) (1.7 
  111
mg, 0.0125 mmol, 0.10 eq) were dissolved in THF (1.0 ml, 6.7 ml⋅mmol−1 105). After 
addition of MVK (37) (12.5 μl, 10.5 mg, 0.150 mmol, 1.20 eq), the reaction mixture was 
stirred at room temperature for 24 h. After the reaction, all volatile components were removed 
in vacuo. The remaining solid was analyzed by 1H NMR (conversion) and chiral HPLC 
(enantiomeric excess). 
 
Conversion: 8% 
 
Enantiomeric excess: ee = rac 
 
5.6. Miscellaneous 
 
5.6.1. Cross-Mannich Experiment 
 
PPh3, phenol
THF, r.t.
NH OTos
Br F
N Tos
+
F
NH OTos
Br
N Tos
+
106 105 103102
53 111
 
 
N-[1-(4-Bromophenyl)-2-methylene-3-oxobutyl]-4-methylbenzenesulfonamide (106) (30.0 
mg, 0.0735 mmol, 1.00 eq) and N-(3-fluorobenzylidene)-4-methylbenzenesulfonamide (102) 
(203.7 mg, 0.735 mmol, 10.0 eq) were dissolved in THF (2 ml, 2.7 ml⋅mmol−1 102) under 
Argon. After addition of triphenylphosphine (53) (19.3 mg, 0.0735 mmol, 1.00 eq) and 
phenol (111) (34.6 mg, 0.367 mmol, 5.00 eq), the mixture was stirred at room temperature for 
n h. The mixture was analyzed by 1H and 19F NMR spectroscopy. 
 
n = 24: no cross-Mannich product (103) 
n = 72: no cross-Mannich product (103) 
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5.6.2. Deuteration Experiment 
 
PPh3
CD3OD, r.t., 24h
O
Br
O
Br
NHTos NDTosH D
D D
106 [D4]106
53
 
 
N-[1-(4-Bromophenyl)-2-methylene-3-oxobutyl]-4-methylbenzenesulfonamide (106) (20.4 
mg, 0.050 mmol, 1.00 eq) and triphenylphosphine (53) (13.1 mg, 0.050 mmol, 1.00 eq) were 
dissolved in [D4]methanol (1.0 ml, 20 ml⋅mmol−1) under Argon. After stirring the reaction 
mixture at room temperature for 24 h, all volatiles were removed in vacuo. The residue was 
dissolved in CDCl3 and characterized via NMR spectroscopy. 
 
1H NMR (300 MHz, CDCl3): δ = 7.55 (d {3JHH = 8.0 Hz}, 2H, Ar), 7.22 (d {3JHH = 7.8 Hz}, 
2H, Ar), 7.16 (d {3JHH = 8.0 Hz}, 2H, Ar), 6.88 (d {3JHH = 7.8 Hz}, 2H, Ar), 6.00 (m, 3H, 
CHH and  CHNH), 5.16 (m, 1H, CHNH), 2.33 (s, 3H, tos-CH3), 2.05 (s, 3H, C(O)CH3) ppm. 
The bold red signals showed a decrease in intensity relative to the other peaks. 
 
5.6.3. Racemization Experiment 
 
PPh3, phenol
THF, r.t.
NH OTos
Br
NH OTos
Br
(S)-106 (R)-106
53 111
 
 
As prototypical example, the racemization of (S)-N-[1-(4-bromophenyl)-2-methylene-3-
oxobutyl]-4-methylbenzenesulfonamide (106) with the combined system PPh3 
(53)/phenol (111) is presented: 
 
To a mixture of (S)-N-[1-(4-bromophenyl)-2-methylene-3-oxobutyl]-4-methylbenzene-
sulfonamide (106) (38.1 mg, 0.0933 mmol, 1.00 eq) and triphenylphosphine (53) (24.5 mg, 
0.0933 mmol, 1.00 eq) in THF (0.75 ml, 8.0 ml⋅mmol−1), phenol (111) (26.3 mg, 0.280 mmol, 
3.00 eq) was added. The resulting solution was stirred at room temperature for n h and 
samples were analyzed by chiral HPLC. 
  113
6. Appendices 
 
6.1. Abbreviations 
 
A   acid 
Ac   acetyl, acetate 
Ar   aryl 
B   base 
BH   Baylis-Hillman 
BINAP  2,2’-Bis(diphenylphosphino)-1,1’-binaphthyl 
BINOL  1,1’-Bi-2-naphthol 
Bmim   butylmethyl imidazolium 
Bn   benzyl 
Boc   tert-butoxycarbonyl 
Bu   butyl 
c   concentration 
conv   conversion 
calc   calculated 
cat.   catalyst, catalytic 
CI   chemical ionization 
COSY   Correlated Spectroscopy, correlation spectrum 
d   doublet, day(s) 
DABCO  1,4-diazabicyclo[2.2.2]octane 
DBU   1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM   dichloromethane 
DFT   Density Functional Theory 
DMAP  4-dimethylaminopyridine 
DMF   N,N-dimethylformamide 
DMSO  dimethylsulfoxide 
ee   enantiomeric excess 
EI   electron ionisation 
er   enantiomeric ratio 
Et   ethyl 
eq   equivalent(s) 
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EVK   ethylvinyl ketone 
EWG   electron withdrawing group 
GC    gas chromatography 
h   hour(s) 
HPLC   High Performance Liquid Chromatography 
HR-MS  High Resolution Mass Spectroscopy 
HX   acid 
Hz   Hertz 
IL   ionic liquid 
IR   infrared 
J   coupling constant 
LAH   lithium aluminiumhydride 
Nos   p-nitrobenzenesulfonyl 
Nu   nucleophile  
m       multiplet, medium 
m   meta 
M   molar 
M+   molecule ion 
Me   methyl 
Mes   methanesulfonyl 
min   minute(s) 
MVK   methylvinyl ketone 
MS   Mass Spectroscopy, mass spectrum, molecular sieves 
MTOA  methyltrioctyl ammonium  
n   normal 
n.a.   not available 
NMR   Nuclear Magnetic Resonance 
NOE   Nuclear Overhauser Effect 
NOESY  Nuclaer Overhauser Effect Spectroscopy 
o   ortho 
obs   observed 
p   para 
P   product 
PG   protecting group 
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Ph   phenyl 
ppm   parts per million 
PTA   1,3,5-triaza-7-phosphaadamantane 
QUINAP  1-(2-Diphenylphosphino-1-naphthyl)isoquinoline 
q   quartet 
quant.   quantitative 
r   reaction rate 
r(0)   initial reaction rate 
R   organic rest 
RDS   rate determining step 
Rf   ratio of fronts (TLC) 
rfl.   reflux 
r.t.   room temperature 
s   singulet, strong  
S   substrate 
SES   β-trimethylethanesulfonyl 
t   time, triplet 
t   tertiary 
T   transmission 
TADDOL trans-α,α'-(Dimethyl-1,3-dioxolane-4,5-diyl)bis(diphenylmethanol) 
TBS   tert-butyldimethylsilyl 
Tf   trifluormethanesulfonyl 
THF   tetrahydrofurane 
TLC   Thin Layer Chromatography 
TOCSY  Total Correlated Spectroscopy 
Tos   p-toluenesulfonate 
TS   transition state 
UV   ultraviolet 
v   very 
vs   very strong 
w   weak 
X   halide  
y   yield 
*   symbol for a stereogenic center 
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6.2. List of Commercially Obtained Chemicals 
 
Reagent Supplier Quality 
3,5-bis-(trifluoromethyl)phenol Aldrich 95% 
Aliquat 336 Acros unknown 
benzaldehyde Avocado 99+% 
benzoic acid Avocado 99% 
benzoylchloride Avocado 99% 
boric acid Merck 99% 
p-bromobenzaldehyde Aldrich 99% 
2-cyclopentene-1-one Avocado 98% 
1,4-diazabicyclo[2.2.2]octane Avocado 97% 
p-dimethylaminopyridine Aldrich puriss, >99.0% 
diphenylacetic acid Avocado 99% 
m-fluorobenzaldehyde Aldrich 97% 
hexafluorobenzene Aldrich 99.9% 
imidazole Avocado 99% 
lithiumaluminium hydride Aldrich 95%, powder 
L-(-)-malic acid Aldrich 97% 
methanesulfonyl chloride Aldrich >99.7% 
methyl acrylate Avocado 99% 
methylvinyl ketone Aldrich 99% 
p-nitrobenzaldehyde Aldrich 98% 
(pentafluorophenyl)diphenyl 
phosphine 
Aldrich 96% 
phenol Aldrich >99% 
tert-butyldimethylsilyl chloride Aldrich solution, 50% (w/w) in 
toluene 
tetraethoxysilane Aldrich >99% 
tetra-n-butylammonium fluoride Aldrich solution, 1M in THF 
thionylchloride Aldrich 99% 
p-tolualdehyde Aldrich 97% 
p-toluenesulfonamide Avocado 98+% 
trans-4-hydroxy-L-proline Acros 99+% 
triethylamine Avocado 99% 
triphenylphosphine Acros 99% 
tris-(o-tolyl)phosphine Strem 99% 
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6.3. Kinetic Study with Phenol as Co-Catalyst 
 
Teilordnung MVK_Add
r(0) = 0,0047c(0)
R2 = 0,9664
0,00E+00
2,00E-04
4,00E-04
6,00E-04
8,00E-04
1,00E-03
1,20E-03
1,40E-03
0,000 0,050 0,100 0,150 0,200 0,250 0,300
c(0) in [mol/l]
r(
0)
 in
 [m
ol
/(l
*m
in
)]
r(
0)
 in
 [m
ol
/(l
*m
in
)]
r(
0)
 in
 [m
ol
/(l
*m
in
)]
r(
0)
 in
 [m
ol
/(l
*m
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)]
 
 
Phenol
r(0)= 0,0045c(0)
R2 = 0,9861
0,000E+00
2,000E-04
4,000E-04
6,000E-04
8,000E-04
1,000E-03
1,200E-03
1,400E-03
0,000 0,050 0,100 0,150 0,200 0,250 0,300
c(0) in [mol/l]
r(
0)
 in
 [m
ol
/l]
 
 
 
 
 6.4. 1H and 13C NMR Spectra of Compound 160 
 
1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
N
ClHO
160
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 6.5. HPLC Chromatogram of Aza-BH Product 106 
 
a) Racemate 
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b) Authentic sample (reaction in IL 166) 
 
 
 
 
 
 6.6. 31P NMR Spectrum of Compound 172 
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6.7. 31P NMR Spectrum of Compound 173 
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